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The objective of this review was to compare the diagnostic accuracy of core needle biopsy 
and fine needle aspiration cytology for patients with a head and neck mass for a diagnosis of 
malignancy using surgical histopathology as a reference test and to compare the risks and 
adverse events associated with each technique. 
Introduction 
A proportion of head and neck neoplasms are malignant which can only be determined by a 
tissue diagnosis. Options for tissue biopsy include - surgical biopsy, fine needle aspiration 
(FNA), and core needle biopsy (CNB). Insufficient tissue for a diagnosis results in additional 
delays in patient management. The diagnostic sensitivity and specificity of each option for 
tissue biopsy in diagnosing a head and neck malignancy has not been evaluated in a meta-
analysis. Our review aimed to compare and review the diagnostic accuracy of FNA and CNB 
for head and neck lesions and assess the risk and adverse events associated with each 
technique. 
Inclusion criteria  
Studies that compared ultrasound guided CNB and/or FNAC to investigate lumps suspicious 
for head and neck malignancy in thyroid, cervical lymph nodes, or salivary gland in adult 





MEDLINE, EMCARE, EMBASE, Web of Science, and the Cochrane Database of Systematic 
Reviews were searched. Studies were critically appraised by two independent reviewers for 
methodological quality using the modified critical appraisal instrument QUADAS2 using JBI – 
SUMARI software. Data was extracted from papers included in the review using a modified 
data extraction tool available in the JBI Reviewer’s Manual. Meta-analysis was performed 
using a random-effects model. Comparison of accuracy of the two techniques was achieved 
by comparing pooled sensitivity and specificity using a bivariable model. The inadequacy rate 
and inconclusive rate were also pooled for comparison. Summary receiver operating 
characteristic (ROC) graphs were created to confirm diagnostic accuracy. Narrative review of 
adverse effects was conducted. 
Results 
Majority of the patients in the included studies compared FNA and CNB for thyroid masses. 
Data on a total of 1229 patients for FNA and 1135 patients for CNB from six studies met the 
inclusion criteria and were included in the final meta-analysis. The studies were of moderate-
low or unknown quality. While CNB and FNA had similar sensitivity and specificity in 
diagnosing thyroid malignancy, the non-diagnostic and inadequacy rate for CNB was 
significantly lower: sensitivity 0.91 (95% CI: 0.79 to 0.96) vs 0.75 (95% CI: 0.66 to 0.83) 
respectively, specificity 1.00 (95% CI: 0.98 to 1.00) vs 1.00 (95% CI: 0.60 to 1.00) 
respectively, non-diagnostic rate 0.043 (95% CI: 0.016 to 0.07) vs 0.164 (95% CI: 0.083 to 
0.245) respectively, inadequacy rate 0.112 (95% CI: 0.087 to 0.137) vs 0.17 (95% CI: 0.106 





Sensitivity and specificity of FNA and CNB for diagnosis of thyroid malignancy for FNA and 
CNB are high. The inadequacy rate and inconclusive rate for CNB is lower than FNA for 
thyroid malignancy. CNB could be used instead of FNA for diagnosis of thyroid nodules if 
found to be cost effective. These results need to be treated with caution as the 
methodological quality of included studies was generally poor, introducing a high risk of bias; 
while substantial differences in study characteristics resulted in significant between study 
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GLOSSARY OF TERMS 
Accuracy – expression of a tests ability to discriminate between people with the target 
condition and those without it.  
Sensitivity - proportion that test positive amongst those having the target condition. 
Specificity - proportion that test negative amongst those without the target condition. 
Negative likelihood ratio - ratio of the proportion that test positive amongst those that have the 
target condition compared to the proportion that test positive amongst those who do not have 
the target condition.  
Negative predictive value - proportion that do not have the target condition amongst those 
that test negative. 
Positive likelihood ratio - ratio of the proportion that test positive amongst those that have the 
target condition compared to the proportion that test positive amongst those who do not have 
the target condition. 
Positive predictive value - proportion that have the target condition amongst those that test 
positive. 
Pre-test probability - proportion with the target condition amongst the group suspected of 
having the condition. 
Receiver characteristic operating (ROC) curve - the sensitivity and specificity of a test vary 
depending on the threshold value chosen. The ROC curve describes the trade-off between 
sensitivity and specificity as the threshold changes. 
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Threshold - the value above or below which a test result is considered positive 
Cost-effectiveness – comparison of both costs (resource use) and consequence 
(outcomes/effects) to determine an intervention’s productivity in relation to its cost. 
Indeterminate - Cytological results that are unable to  differentiate between malignant and 
benign nodules with confidence 





1.1 The Historical Context of Systematic Reviews 
Literature reviews became popular as a means of bringing together articles in support of a 
position or argument in the 1960s, or to present a narrative overview of a topic in fields such 
as psychology, education and the social sciences.1, 2  Early literature reviews summarised the 
findings of several studies on the same topic using similar measures, however, concerns with 
quality, transparency and reliability were compounded by a lack of standardised 
methodology.3 Systematic reviews became popular as a field of science in response to the 
need for increased rigor and reliability, while reducing the risk of bias and systematic error 
which was considered a limitation of literature reviews. Evidence-based Medicine (EBM) was 
introduced in the early 1990s to assist clinicians that were increasingly relying on healthcare 
literature to make management decisions.1 With the increase in the number of primary 
studies, it became apparent that all available evidence needed to be synthesised within a 
particular domain to help clinicians make truly evidence informed decisions. Early review 
articles lacked systematic and statistical methods to derive reliable estimates of treatment 
effects and consequently were prone to biased and inaccurate conclusions.1  
Literature can be reviewed systematically to reduce the risk of bias using a diverse range of 
methods to serve the demands of various research and policy domains. These methods are 
guided by the type of evidence being reviewed; quantitative and qualitative methods are 
common to EBM.1 Quantitative evidence is produced by the study of natural and social 
sciences using traditional scientific methods that generate numerical data.4 Quantitative 
research includes the use of statistical methods to assess effectiveness, incidence, 
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prevalence, aetiology of disease, quality of life, satisfaction and care. Quantitative reviews 
include the synthesis or statistical analysis of primary quantitative studies, preferreably using 
an established, transparent and rigorous methodology. Alternately, as a contribution to 
evidence-based healthcare, analysis of human experience and cultural and social 
phenomena can be studied by qualitative methodologies.5 Qualitative evidence holistically 
draws on complex human phenomena in naturalistic (uncontrolled) settings.6 Examples of 
qualitative methodology include ethnography, phenomenology, qualitative enquiry, action 
research, discourse analysis and grounded theory.7 In the healthcare context, qualitative 
research seeks a deeper understanding of the experience, attitudes, beliefs and perspectives 
of clinicians and patients. This evidence is produced by observation (either direct or indirect) 
or by conducting individual or group interviews. Quantitative and qualitative systematic 
reviews synthesise the evidence base to help clinicians and policy makers identify feasible, 
appropriate, meaningful and effective healthcare practices to improve healthcare outcomes. 
Within the scientific consensus associated with evidence for healthcare, it is now increasingly 
recognised that the methodological rigor with which a review is executed is equally pertinent 
to the strength of evidence provided by the included study designs.3, 8 The strength, and 
certainty (or confidence) of conclusions drawn from systematic review results depend on the 
precision of the review question, the inclusion and exclusion criteria, and the data extraction 
techniques.8 To achieve the level of rigour and quality equivalent to primary studies, 
systematic reviews require an a-priori protocol, a systematic, comprehensive search, 
appraisal of the internal validity of included studies and transparent methods of synthesising 
research evidence while adhering to guidelines on the conduct and reporting of the review.3 




Table 1 Differences between systematic review and literature reviews1, 8 
 Literature review Systematic review 
Aim Provides current 
thinking/context of several 
aspects of a topic without a 
specific question. 
Answers a precise question, 
using a predetermined 
method detailed in a study 
protocol.  
Data collection Search of selected 
databases unsystematically. 
Use of grey literature 
common. 
Comprehensive search 
strategy of several specified 
databases, search of gray 
literature may be included. 
Data extraction Subjective interpretation of 
study’s conclusions. 
Use of a pre-specified data 
extraction tool to collect data 
congruent to outcome 
measures. 2 researchers 
usually extract data. 
Inclusion criteria No explicit inclusion criteria. Criteria for inclusion pre-
defined in terms of 
participants, intervention, 
comparator and outcome 
(PICO).  
Data analysis No clear indication of 
methodological assessment. 
Often unsystematic 
compilation of randomly 
selected studies. 
Use of standardised critical 
appraisal tools/checklists to 
identify bias and 
methodological quality and 
strength of evidence.  
Data synthesis and 
presentation 
Typically, narrative using 
chronological/conceptual or 
thematic summarisation with 
no clear explanation 
regarding how conclusions 
are drawn. 
Use of PRISMA, tabular 
summarisation of data with 
statistical pooling where 
possible or narrative. 
Outcome Recommendation informed 
by evidence drawn from 
various included studies. 
Actions/directions for 
practice, identifies gaps in 
knowledge and uncertainty of 
findings (if any) and 
recommendations for future 
research based on evidence 




It is important to note at this point that meta-analysis is an analytic technique that statistically 
combines the results of quantitative studies to provide an augmented numerical analysis of 
the included studies, it is not a term that is analogous with the term ‘systematic review’.1 
Meta-analysis should only be conducted as part of a systematic review if the following criteria 
are met:9 
• Clinical homogeneity - Similarity in study participants in terms of age, the disease state 
that allows for pooling of data and generalisation for the chosen population 
• Methodological homogeneity - Similarity in study designs and methods for combining 
data 
• Statistical homogeneity: low heterogeneity as demonstrated by statistical tests of 
heterogeneity such as the Cochran’s Q test and I2 statistic.  
1.2 The Context of this Review  
Literature suggests that persistent head and neck masses in adult patients should be 
considered malignant until proven otherwise.10 Delay in diagnosis can affect tumour stage 
and prognosis with poorer functional outcome after treatment and increased mortality.11 
Diagnosis can be complicated as a wide spectrum of non-neoplastic and neoplastic pathology 
presents as head and neck masses in adult patients. Underlying aetiologies responsible for 
head and neck masses include infectious, inflammatory, congenital, traumatic, benign or 
malignant neoplastic processes. Head and neck cancers account for the 9th most common 
cancer in the world and the 7th most common cancer in Australia, with increasing incidence 
and mortality in both developed and developing countries.12, 13 Presence of a persistent head 
and neck mass prompts urgent investigation and management as this can be the initial or the 
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only clinically apparent manifestation of head and neck cancers, namely squamous cell 
carcinoma (HNSCC), lymphoma, skin, thyroid or salivary gland cancer.  
History and physical examination findings suggestive of a malignant process include local or 
referred pain, voice change, neck mass, dysphagia, weight loss, stridor or bleeding. The signs 
and symptoms prompt imaging with computed tomography (CT), magnetic resonance 
imaging (MRI) or high-resolution ultrasound.14 While these imaging modalities can provide 
useful information about head and neck tumours, they are unable to definitively determine 
whether a lesion is malignant or benign.15 Tissue diagnosis is a standard requirement for 
clinical management as it provides the pathological status of masses. Tissue diagnosis can 
be achieved with fine-needle aspiration (FNA), core needle biopsy (CNB) or open surgical 
biopsy.  
Timely and standardised assessment of pathology pre-operatively has several advantages. 
These include triaging of patients in planning the type and timing of operative intervention;, 
consideration of pre-operative adjuvant/neoadjuvant therapy (if indicated); and prevention of 
unnecessary surgery in select patients that can be observed and managed conservatively 
(Warthin’s tumour) or those that require non-surgical management (lymphoma).16 Historically, 
many head and neck lesions were treated by surgical excision under a general anaesthetic, 
serving both diagnostic and therapeutic purposes.16 However, open surgical biopsy or lymph 
node excision is an invasive option to provide adequate histological information as it often 
requires a hospital admission, and has a higher risk of complications such as bleeding, 
incomplete or inadequate excision, and wound infections as compared to FNA and CNB.17 In 
the recent guidelines, open surgical biopsy is contraindicated in cases of suspected 
malignancy due to the increased risk of tumour seeding, reduced survival rates and increased 
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risk of malignancy recurrence after treatment.16, 18, 19 Consequently, less invasive methods 
have evolved to diagnose masses that are indeterminate based on clinical information 
provided by history, exam, laboratory and imaging modalities. 
Fine needle aspiration (FNA) and core needle biopsy (CNB) provide less invasive alternatives 
to open surgical biopsy for diagnosis of head and neck cancers. Although both FNA and CNB 
have similar safety profiles, at present FNA is the recommended initial diagnostic technique 
because it is rapid and cost-effective.18 CNB provides tissue diagnosis with preserved 
histological architecture and is the preferred diagnostic test in the diagnosis of lymphoma and 
in patients that have received previous head and neck irradiation.18, 20, 21  The main objective 
of this systematic review was to compare the diagnostic accuracy of FNA and CNB for 
neoplasia and malignancy and assess the risk of adverse events associated with each 
technique. 
1.3 Studies of Diagnostic Test Accuracy 
Health professionals, policymakers and patients depend on effective, appropriate, feasible 
and meaningful research to make informed, evidence-based decisions.22 Evidence-based 
healthcare integrates clinical expertise with the best available evidence while taking into 
account patient preference. 
Clinicians use diagnostic tests to determine if a disease or condition is present or absent, this 
directly informs management plans. Diagnostic tests encompass signs and symptoms 
observed while taking a history or examining the patient, psychological investigations, and 
investigations such as biochemical technologies, pathology, and imaging.23  
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As science advances, a better understanding of the aetiology of diseases and ever 
progressing technological innovations has resulted in the development of advanced 
diagnostic tests with improved accuracy, efficiency, safety, and cost-effectiveness. This 
advancement has been accompanied by research efforts to test the accuracy of new and 
existing diagnostic tests.24 Diagnostic test accuracy is defined as a test’s capacity to 
distinguish between people with the the target condition and those without it.25 Measures of 
test accuracy include: sensitivity and specificity; positive and negative predictive values; 
positive and negative likelihood ratios.25   Evaluation of diagnostic accuracy involves 
comparing the results of the index test i.e. the novel test with those obtained using a standard 
reference test, in a population of patients suspected of having the disease.26  
Summary statistics for test accuracy are conventionally presented in a two by two table that is 
obtained by comparing the index test (test outcome) with the reference standard (disease 
state) as shown in Table 2.  
Cell ‘a’ are those patients that the test correctly diagnosed with the disease, these are true 
positives (TP). Cell ‘b’ are those patients that have a positive test result but do not have the 
disease as per the reference standard, these tests are false positives (FP). Cell ‘c’ are those 
patients that have the disease but were incorrectly labelled as non-diseased by the index test, 
these tests are false negatives (FN). Cell ‘d’ labelled true negatives (TN) are those patients 
that do not have the disease and appropriately had a negative test result.  
Table 2 Classification of test results and disease status in a 2x2 table 
Test outcome 
(index test) 
Disease/condition status  
Diseased Disease absent Total 
Test positive True positives (a) False positives (b) Test positives (a+b) 
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Sensitivity is defined as the percentage of patients with positive index test results that have 
the disease, i.e. the test correctly classifies an individual as ‘diseased’ (from Table 2 a/a+c). 
Specificity is defined as the percentage of patients that correctly have a negative index test 
i.e. the test correctly classifies an individual as disease free (from Table 2 d/b+d).27 In practice 
a highly specific test if positive rules the disease in, while a highly sensitive test if negative 
rules the disease out. It is important to note that measures of test accuracy depend on the 
threshold that defines the value above or below which a test result is considered positive.25 
Sensitivity and specificity are dependent on the threshold/cut off of the index test. If a test is 
considered positive above a certain threshold and negative if the result is below the cut-off, 
decreasing the cut-off decreases the number of false negatives and consequently increases 
the sensitivity of the test. However, decreasing the cut-off will also result in higher false 
positives, thus decreasing the specificity. It is therefore important to account for the threshold 
used when interpreting sensitivity and specificity data. Sensitivity and specificity help us 
identify the utility of a test in making a diagnosis, but do not indicate whether a positive result 
truly signifies the presence of the disease. There are other alternatives proposed to assess 
test accuracy28 such as predictive values and likelihood ratios29 that provide this information.   
Predictive values provide the probability of the diagnostic value of the result of the test i.e. the 
proportion of patients who are correctly diagnosed.30 The positive predictive value is the 
proportion of individuals with positive test results that are correctly diagnosed (from Table 2 
a/a+b). The negative predictive value is the proportion of individuals with negative test results 
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who are diagnosed correctly (from Table 2 d/c+d). Predictive values are directly related to the 
prevalence of the disease.31 Prevalence also referred to as pretest probability is the 
proportion of the population that has the disease at any given time.  populations with higher 
disease prevalence have higher positive predictive values and lower negative predictive 
values.32 Sensitivity and specificity are not mathematically affected by the prevalence of the 
disease, and therefore the estimated false positive and false negative results remain constant 
across populations with different disease prevalence.33 
Likelihood ratios assess the probability that the test result obtained would be expected in a 
person with the condition, compared to the probability that the same result would be seen in a 
person without the condition. Positive likelihood ratios express how likely it is that people will 
receive a positive test compared to those who do not have the condition. Negative likelihood 
ratios express how many times more likely it is that people with the condition will receive a 
negative test compared to those who do not have the condition.23 A likelihood ratio is 
particularly useful when index test results can be divided into more than two outcomes rather 
than just positive and negative. For example, a test may be strongly positive, weakly positive, 
or negative and likelihood ratios for each test result can be calculated.34 Additionally, the 
clinical utility of the test can be determined by comparing the pretest to posttest probability of 
the disease. A test is generally more useful if the pretest to posttest probability of the disease 
increases or decreases significantly. 
Evaluation of diagnostic tests is important for policymakers to determine funding and 
availability of tests.35 Clinicians and policymakers require a thorough assessment of the new 
and upcoming tests and their ability to accurately diagnose the condition of interest. Transition 
to newer diagnostic tests should be guided by the comparative cost, ease of performance, 
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patient safety and accuracy of the test.26  If the new test obviates the need for further 
investigation without reducing accuracy and results in appropriate and effective therapy in a 
safe and timely fashion, the new diagnostic test could be preferentially used;36 ultimately 
impacting clinical practice and patient outcomes.  
1.4 The science of synthesising evidence of diagnostic test accuracy 
Systematic reviews of diagnostic test accuracy (DTA) systematically identify, select and 
critically appraise relevant research to analyse data from primary studies of diagnostic 
accuracy.25 Systematic reviews and meta-analyses can provide more valid summary 
estimates of diagnostic tests24 than individual DTA studies, that can help guide clinicians and 
policymakers. Additionally, systematic reviews can provide information on covariates that 
affect tests’ diagnostic accuracy and help identify areas for further research.24 A well-
conducted systematic review of high quality diagnostic studies is the highest level of 
diagnostic evidence.37  
A meta-analysis is a component of systematic reviews that integrates the results of primary 
research studies with specialised statistical methodology.38 Meta-analysis requires 
homogeneity between key characteristics of included studies. However, differences in patient 
populations due to small sample sizes or patient selection, methods, measurement 
instruments and outcomes contribute to between study heterogeneity.35 In addition, the 
results of diagnostic tests can vary at different stages of the disease or with different test 
interpretations and interpreters.39  
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1.5 Anatomical subsites of Head and Neck Masses 
1.5.1 Thyroid nodules 
A thyroid nodule is a radiologically distinct lesion within the thyroid gland different from the 
surrounding thyroid parenchyma.40  The incidence of palpable thyroid nodules is between 4-
7% in the general population.41 Extensive use of imaging has resulted in more frequent 
detection of thyroid nodules with up to 67% of adults being diagnosed with ‘incidentalomas’.42   
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Table 3 classifies the different types of thyroid nodules. With 7-15% of thyroid nodules being 
malignant, it is imperative to rule out thyroid cancer when investigating a nodule.43, 44 In 
Australia, it is estimated that approximately 3,615 new cases of thyroid cancer would be 
diagnosed in 2019.45 Thyroid cancer has the greatest percentage increase in the age-
standardised incidence from 3.7 to 13 per 100,000 persons between 1982 and 2019.13 This 
may be attributed to increased surveillance and introduction of neck ultrasonography.46 In 
2016, 140 deaths were attributed to thyroid cancer in Australia and the overall 5-year survival 
rate of thyroid cancer is 97%.45  
A preoperative diagnosis facilitates informed patient consent in surgical cases and helps 
provide appropriate treatment of patients at high risk of thyroid cancer mortality and morbidity. 
It is important to rule out malignancy to avoid unnecessary overtreatment, anxiety, and 
suffering that diagnostic surgery causes in patients with benign neoplasms. Serum 
thyroglobulin level, radionuclide and cross-sectional (CT and MRI) imaging and 
ultrasonography can provide useful information in the differential diagnosis of thyroid nodules. 
However, these investigations are unable to definitively diagnose the neoplastic nature of the 




Table 3 Histopathological classification of thyroid nodules(67, 70, 71) 















Thyroid cysts Simple or haemorrhagic 
cysts 
Neoplastic   
Benign Follicular adenoma 10-15% of all thyroid nodules 
Malignant  7-15% of all thyroid nodules 
Papillary carcinoma 70-80% of all thyroid cancers 
Follicular carcinoma 15-20% of all thyroid cancers 
Hurthle cell carcinoma A less common subtype of follicular 
carcinoma 
Medullary carcinoma 4% of all thyroid cancers 
Anaplastic carcinoma 1% of all thyroid cancers 
 Primary thyroid 
lymphoma 
 




1.5.2 Salivary gland neoplasms 
Salivary gland neoplasms are rare and represent a variety of both benign and malignant 
histological subtypes summarised in Table 4. In 2009 salivary gland cancers accounted for 
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6.8% of new head and neck cancers.47 The mortality from salivary gland cancers varies by 
stage and pathology, with an overall 5-year survival rate of 70.4%.47 
Amongst salivary gland tumours, 80% arise in the parotid glands, 10-15% arise in the 
submandibular gland, and the rest arise in sub-lingual and minor salivary glands.48 Salivary 
gland tumours present as an enlarging mass and may be associated with neurological signs 
such as facial nerve paralysis. Clinical features suspicious for malignancy include pain, fixed 
tumour, ipsilateral facial nerve palsy, and cervical lymphadenopathy.48, 49 Cross-sectional 
imaging with CT and MRI scans are useful adjuncts for operative planning but preoperative 
cytological or histological diagnosis is imperative as the indication for and extent of surgery is 
determined by the diagnosis.   
Table 4 Common salivary neoplasms(114) 




Benign Pleomorphic adenoma 







Malignant Mucoepidermoid carcinoma 
Adenoid cystic carcinoma 
Acinic cell carcinoma 
Carcinoma Ex-pleomorphic adenoma 
















1.5.3 Cervical lymphadenopathy 
An abnormal congenital or acquired lesion that is visible, palpable or seen on imaging below 
the mandible, above the clavicle and deep to the skin is defined as a neck mass.18 A variety 
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of benign and malignant pathologies present as lymphadenopathy or unclear masses of the 
neck15 these are summarised in   
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Table 5. Infectious lymphadenopathy is the most common cause of neck masses in children; 
however, most persistent masses in adults are due to neoplasms.18 Presentation with 
asymptomatic neck mass may be the first manifestation of a malignancy such as squamous 
cell carcinoma (HNSCC), lymphoma, thyroid or salivary gland cancer.18 Adults with a 
persistent neck mass need to be investigated in a timely fashion to rule out malignancy as 
tumour growth within the regional lymph nodes from metastatic spread can result in a neck 
mass.50 Mucosal HNSCC may originate in the nasopharynx, oral cavity, oropharynx, 
hypopharynx or larynx.18 A delayed diagnosis can result in a poor prognosis, progression of 
HNSCC and lymphoma, and poorer functional outcomes.11, 51-53  
In 2019, the estimated number of new cases of head and neck cancer and lymphoma 
diagnosed in Australia was predicted to be 5212 and 6423 accounting for the 7th and 6th 




Table 5 Cervical lymph node pathology(14) 




Epstein Barr virus 
Staphylococcus or streptococcal infection 
Toxoplasmosis 
Tuberculosis 
Human immunodeficiency virus 
Viral upper respiratory tract infection 
Neoplastic Parotid lymphadenopathy 
Squamous cell carcinoma of the upper 
aerodigestive tract 
Hodgkin lymphoma 




Inflammatory Acute sialadenitis 
Congenital Branchial cleft cyst 




Idiopathic Castleman disease (angiofollicular 
lymphoproliferative disease) 





1.6 Biopsy Assessment of Head and Neck Pathology  
1.6.1 The Use of Fine Needle Aspiration 
Fine needle aspiration (FNA) was popularised in Scandinavia and Europe in 1952 to retrieve 
cellular material for cytological examination.56 FNA was recognised in North America as the 
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preferred diagnostic technique for evaluating masses of different sites in the late 1980s.57, 58 
Over the years, FNA has become the recommended test for preoperative cytological 
assessment of almost all body lesions including head and neck masses.59 Since the 
introduction of FNA, the number of unnecessary surgeries has reduced significantly.60  
Fine needle aspiration is performed using a 21-28-gauge needle through suction or capillary 
action to draw cellular material that is transferred to a glass slide, which is fixed and dried to 
allow for microscopic evaluation. FNA can be performed in an outpatient, clinic setting by 
palpation and insertion of a needle into the tumour and aspiration by the cytopathologist, 
surgeon, or physician.61, 62 
In 2009, the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) was 
developed to standardise the terminology and morphologic criteria related to thyroid FNA and 
relay their associated malignancy risks.63 All thyroid pathological reports are reported 
according to TBSRTC or British Thyroid Association Guidance, or other country/region 
specific guidelines. The TBSRTC was updated in 2017, with the revision of malignancy risks 
based on more recent (post-2010) data and updated evidence-based clinical management 
recommendations, summarised in Table 6.64      
1.6.1.1 Thyroid nodules – Fine Needle Aspiration 
19 
 

















Thy1 Cyst fluid only 
Virtually acellular 
specimen 
Other (Obscuring blood, 
clotting artefact, etc.) 
5-10 Repeat FNA 
with ultrasound 
guidance 
Benign Thy2 Consistent with a benign 
follicular nodule (includes 
adenomatoid nodule, 
colloid nodule, etc.) 
Consistent with 
lymphocytic (Hashimoto) 
thyroiditis in the proper 















































Thy4 Suspicious for papillary 
carcinoma  
Suspicious for medullary 
carcinoma  
Suspicious for metastatic 
carcinoma  
Suspicious for lymphoma 
Other 
50-75 Near total 
thyroidectomy 
or lobectomy 

















Bongiovanni et al in 2012 investigated the validity of Bethesda System for Reporting Thyroid 
Cytopathology (TBSRTC) through meta-analysis. A total of 6,362 (25%) of 25,445 thyroid 
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FNAs underwent surgical excision and this subgroup was used to determine the accuracy of 
TBSRTC.65 The meta-analysis found the sensitivity, specificity, and accuracy to be 97, 50.7 
and 68.8%, respectively. The meta-analysis concluded a high overall accuracy indicating that 
TBSRTC is a reliable and valid reporting system for thyroid cytology.65 There are no 
standardised reporting systems for salivary gland and cervical lympahadenopathy for FNA or 
CNB.  
Preoperative tissue diagnosis plays an important role in treatment decisions and patient 
counseling for salivary gland lesions. A malignant preoperative diagnosis can help prepare 
the patient in terms of extent of surgery, the need for neck dissection or postoperative 
radiotherapy. A meta-analysis published in 2011 that analysed 64 studies concluded that FNA 
had high specificity (97%) but a lower sensitivity (80%) with a relatively high false negative 
rate (20%) in salivary gland FNA.66  
Current clinical practice guidelines for evaluation of neck masses in adults strongly 
recommend clinicians perform FNA or refer patients considered to be at increased risk of 
malignancy to someone who can perform FNA.18 A meta-analysis of 782 cervical lymph node 
aspirates reported high sensitivity and specificity with 94.2% and 96.9% respectively. 67 
1.6.2 Optimisation of Fine Needle Aspiration 
Fine needle aspiration is widely accepted because of its many advantages including rapid, 
relatively safe, cost-effective and accurate results. However, it has become increasingly 
apparent that FNA can be associated with high non-diagnostic rates. The diagnostic yield of 
FNA can be improved by the use of ultrasound-guidance, rapid onsite evaluation of the 
1.6.1.2 Salivary gland – Fine needle Aspiration 
1.6.1.3 Cervical lymphadenopathy – Fine needle Aspiration 
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aspirate, and use of ancillary techniques.68-70 The use of real time image guidance with 
ultrasound has several advantages including provision of important information regarding the 
site of origin, the ability to biopsy non-palpable lesions and lesions less than a centimeter, 
improved accuracy in sampling heterogeneous nodules, and avoidance of adjacent vessels, 
implants, and other important structures.71, 72 Ultrasound guided FNA performed by surgeons 
as well as cytologists have shown higher specificity, negative predictive value and sensitivity 
in recent studies along with fewer non-diagnostic samples compared to palpation guided 
FNA.72-75 A randomised controlled trial performed by head and neck surgeons in an office 
based setting, reported a significant comparative diagnostic advantage with adequacy rate of 
87% for ultrasound guidance versus 60% for standard palpation based biopsy.73 Conrad et al 
in 2018 demonstrated significant reduction in nondiagnostic results for cytopathologist using 
ultrasound guided FNA (6.6%) versus palpation guided FNA (21.2%).72 
Availability of onsite cytology allows for detection of inadequate samples and re-aspiration of 
the lesions as indicated, and provision of interim diagnosis.76-78 Recent advances in liquid 
fixation allow for multiple thin-layer preparations and enhanced ability to perform 
immunohistochemistry that may help further refine diagnosis.67  Molecular testing e.g. 
BRAFV600E mutation for papillary thyroid cancer is gaining popularity and may assist in 
determination of benignity in thyroid aspirate samples; however, molecular testing for FNAC is 




Shortcomings of Fine Needle Aspiration  
Despite optimisation of fine needle aspiration with ultrasound-guidance, rapid onsite 
evaluation of the aspirate, and ancillary testing, an ongoing concern with FNA is the non-
diagnostic samples. Inadequate sampling results in diagnostic delays and unnecessary 
surgery in 10-15% of cases.67 This has been noted as a pitfall across all head and neck 
subsites. FNA of thyroid nodules has been found to have a high rate of 
inadequate/unsatisfactory samples resulting in failure to provide a definitive diagnosis. 
Similarly, a systematic review assessing the diagnostic accuracy of FNA for salivary gland 
tumours demonstrated an inadequate sample rate of 8.6%. The non-diagnostic rate for 
cervical lymphadenopathy FNA without ultrasound guidance ranged from 3% to 30% in a 
systematic review of 782 lymph nodes.67  
Repeat FNA with ultrasound guidance has been shown to provide a definitive diagnosis in 
only 50% of the cases for thyroid FNAs with non-diagnostic results.79 If ultrasound or clinical 
findings are suspicious for malignancy, diagnostic surgery is recommended for persistently 
non-diagnostic FNA results.40 Bongiovanni et al in 2012 conducted a meta-analysis in a 
pooled population of 25,445 FNA biopsies of thyroid nodules and found that 8.4% of non-
diagnostic FNA patients underwent diagnostic surgery, and majority of the cases were 
ultimately benign that could have been managed conservatively (83.2%).65  
Indeterminate samples result in inability to distinguish between non-neoplastic, benign and 
malignant thyroid follicular lesions.80, 81 Cytological results that are unable to  differentiate 
between malignant and benign nodules with confidence form the inconclusive category of 
FNA results for thyroid nodules.64 Bethesda categories included in this sub-group are 
1.6.2.1 Non-Diagnostic results 
1.6.2.2 Indeterminate results 
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“follicular lesion/atypia of undetermined significance (AUS/FLUS)” and “follicular 
neoplasm/suspicious for follicular neoplasm (FN/SFN)”. Bongiovanni et al in a meta-analysis 
reported that 9.6% of all FNAs were AUS/FLUS and FN/SFN contributed to 10.1% of all 
FNAs. 65The diagnostic surgery rate for AUS/FLUS was 39.2% and 69.7% for FN/SFN, with a 
malignancy rate of 15.9% and 26.1% respectively. There appears to be no universal 
consensus on the management of this subcategory. Some guidelines recommend repeat 
FNA, while others recommend a hemithyroidectomy, the Korean guidelines recommend core 
need biopsy.40, 82 83 Repeat FNAC has been found to provide a definitive cytological diagnosis 
in some patients but up to 30% of patients continue to have an indeterminate result.84-86  
FNA has also been found to have indeterminate results for paucicellular cysts or neoplasms 
of salivary gland lesions with overlapping features such as cellular pleomorphic adenoma, 
adenoid cystic carcinoma and lesions with minimal cytological atypia (e.g. low-grade 
mucoepidermoid carcinoma and acinic cell carcinoma) and malignant lymphomas.87 
A systematic review of 78 studies reported an overall inadequacy rate of 9.3% for patients 
undergoing head and neck FNAs.71 The review also concluded that different operators 
contribute to variation in the inconclusive rate as does the presence of onsite cytology.71 FNA 
cytology is also unable to differentiate between subtypes of lymphoma and cannot reliably 
distinguish between certain salivary and thyroid tumours.18, 62, 88 A systematic review 
published in 2008 including 30 studies with 3459 aspirates from all head and neck sites 
reported that FNA was unable to reliably differentiate between follicular adenoma or benign 
hyperplastic nodules from carcinoma for thyroid nodules.67 
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1.6.3 An Alternative: Ultrasound guided Core Needle Biopsy 
Core needle biopsy is performed under local anaesthetic with semi-automated or fully 
automated side-cut or end-cut 16-20-gauge needles.15 Cylindrical intact tissue is harvested, 
preserving tissue architecture, in turn, reducing the inadequacy rates. The biopsy is formalin-
fixed and paraffin-embedded allowing for more reliable immunohistochemical testing than 
FNA smears and centrifuged preparations. A larger gauge needle provides enough tissue 
material for immunophenotyping of the tumour allowing for tests like flow cytometry, Human 
papillomavirus (HPV) testing, and p16 immunohistochemistry. Novoa et al in 2012 published 
a systematic review including 26 studies and a total of 1291 core needle biopsies 
demonstrated an overall accuracy of 96% in detection of malignancy.20 Table 7 compares the 
diagnostic accuracy of FNA and CNB from systematic reviews assessing FNA and CNB for 
head and neck masses.  
Table 7 Results of previous diagnostic accuracy studies for head and neck masses. 
 Fine needle aspiration67 Core needle biopsy20 
Overall accuracy (range) 93.1% (73.3-98%) 96% 
Overall sensitivity 89.6% 93% 
Specificity 96.5% 99% 
Positive predictive value 96.2% 98% 
Negative predictive value 90.3% 95% 
 
In the case of repeated indeterminate and AUS/FLUS results for thyroid nodules, an 
ultrasound-guided CNB is an alternate low morbidity intervention to obtain tissue diagnosis 
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instead of diagnostic surgical excision.89 The result of a core biopsy may change further 
management especially when lymphoma is suspected. Core biopsy provides more sample 
tissue thus increasing the adequacy rate.90, 91 It is well tolerated by patients and has minimal 
reported complications.92 A systematic review and meta-analysis of 39 studies published by 
Ha et al in 2018, reported a low pooled complication rate with a core needle biopsy.92 Core 
needle biopsy can effectively differentiate between anaplastic thyroid cancer and lymphoma 
which have a similar presentation of rapidly increasing neck mass.93 Core needle biopsy has 
some limitations, including the need for local anaesthesia and local discomfort. Although 
scarce, there are dated reports (from mid 1900s) in the literature of needle track tumour 
implantation, haemorrhage and recurrent laryngeal nerve damage but these complications 
are not specific to CNB and also apply to FNA.58, 94, 95 
Although many studies have assessed the diagnostic accuracy of FNA and CNB individually 
for the salivary gland, thyroid gland and cervical lymph nodes, this specific body of literature 
has not been compared, reviewed and analysed systematically.20, 67, 71, 96-99 
1.6.4 Risks and complications of fine needle aspiration and core needle biopsy 
Fine needle aspiration and core needle biopsy are considered safe sampling procedures that 
can be performed in the outpatient setting. CNB requires the use of local anaesthesia and is 
therefore slightly more time-consuming.  
A few case studies reported uncontrolled haemorrhage and massive haematomas post 
palpation guided FNA resulting in acute upper airway obstruction requiring hospital admission 
and active intervention; however, these were rare case reports from the late 1980s.100-102 
A systematic review summarised all reported complications post thyroid FNA, noting self-
limiting, localized pain and haematoma as the most common complications.103 Post 
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procedure infections, transient recurrent laryngeal nerve dysfunction and tumour 
dissemination were noted to be rare occurrences.103 The review concluded that in the hands 
of experienced operators FNA was a safe and effective biopsy technique and awareness of 
possible complications is important for informed consent.103 Similarly, Schmidt et al conducted 
a systematic review assessing diagnostic accuracy of FNA in salivary gland masses in 2011 
and reported the haematoma rate to be 1.6% per procedure with no cases of permanent 
facial nerve injury or tumour seeding in 512 procedures.66  
Kim and Kim in 2018 reported a haematoma rate of 0.5% for CNB for 1315 procedures 
confirming the safety of CNB.97 Ha et al conducted a systematic review and meta-analysis of 
complications following ultrasound guided core needle biopsy of thyroid nodules and 
concluded that various complications can occur after ultrasound guided CNB but the pooled 
complication rate was 1.11%, with major complications accounting for 0.06%.104   
Nasrollah et al investigated and compared patient comfort and tolerability of FNA and CNB for 
thyroid nodules.92 A total of 61 consecutive patients that underwent both biopsies were asked 
to fill out structured questionnaires to assess their comfort during the procedures. The 
majority of the patients reported pain during both biopsies (95%), 2 patients reported pain 
only during CNB, and one reported no pain. Complaints of local pain after FNA were reported 
in 29% of the patients, while post-CNB pain was reported in 45% of patients. Patients 
reported comparable tolerability of FNA and CNB, 82% and 83% respectively. Stangierski et 
al compared pain post core needle biopsy after a failed FNA using a visual analog scale, and 
the median score for CNB was 4/10.105 Approximately 60% of the patients thought the pain 
was similar to the pain experienced during conventional FNA, while 40% reported that the 
pain was ‘slightly stronger’ than FNA. This shows a discordance in the literature with limited 
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good quality epidemiological data assessing local pain and discomfort post-FNA and CNB 
procedures.  
The type of tumour and anatomic site contributes to the potential risk of seeding; however, a 
large study of 11,700 abdominal biopsies performed with FNA demonstrated low rates of 
tumour seeding (0.017%).106 This was further confirmed by a study of salivary gland biopsies 
that demonstrated the presence of salivary adenomas along the needle track (22g needle) but 
this did not lead to tumour recurrence at five year follow up.107 A study compared the 
incidence of post salivary gland biopsy seeding and found only 2 cases of tumour seeding 
after 14G CNB, with 2 cases also described post FNA.108 As seeding can present up to 20 
years post-biopsy, ongoing close follow up is recommended to identify any long term 
complications associated with seeding.109 Another option to avoid seeding is to excise the 
biopsy tract when surgical excision is performed but there is no evidence to support this 
routinely.110 A systematic review conducted by Shah et al assessed 575 studies including 
41,468 FNAs and 35 studies including 1803 CNBs of head and neck masses, predominantly 
case series and case reports due to the extremely low incidence of needle track seeding.111 
The crude estimate for seeding post- procedure was 0.00012% and 0.0011% after FNA and 
CNB respectively.111 In context of clinically relevant tumour development/recurrence the risk 
of seeding was found to be very low.111 Overall, both FNA and CNB are safe procedures with 
low complication rates. 
1.7 Justification of need for evidence synthesis in this area 
Percutaneous biopsy techniques are critical for surgical management of head and neck 
masses and have become the standard of care in preoperative diagnosis of neoplasms and 
malignancy. Investigation with imaging modalities such as ultrasound, CT and MRI provides 
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valuable information to guide treatment planning for these patients. However, in the context of 
tailoring management, tissue diagnosis helps identify the subset of patients who could 
potentially be managed conservatively and helps determine the extent of surgical resection. A 
meta-analysis by de Bondt et al in 2017 including 17 articles concluded that ultrasound 
guided FNA is more accurate than ultrasound, CT and MRI in detecting cervical lymph node 
metastases.112 Ultrasound features of thyroid nodules such as marked hypo-echogenicity, 
irregular margins, micro-calcifications or ‘taller than wide’ shape suggest malignancy with 
sensitivity of up to 87%, specificity of 83.1%  and a high negative predictive value of 95.7%.113 
The high specificity reduces the number of unnecessary FNAs performed due to the low false 
positive rates. These features help identify patients that should undergo further investigation 
with percutaneous biopsy but cannot replace tissue diagnosis.40   
Fine needle aspiration of palpable, superficial lesions such as enlarged lymph nodes, thyroid 
nodules and salivary gland lesions can be performed by different clinicians including 
endocrinologists, haematologists, cytopathologist, radiologists and surgeons. Traditionally, 
FNA was performed without any image guidance. However, ultrasound guided FNAs by 
interventional radiologists has gained popularity in the recent times.72 The guidelines for 
investigation and management of thyroid nodules as well as head and neck lesions 
recommend fine needle aspiration as a first line biopsy technique, and a repeat ultrasound 
guided fine needle aspiration if inadequate specimen is obtained.18, 40, 82, 83, 114 
Ultrasound guided FNA has been reported to have high sensitivity and specificity and has 
been accepted as the preferred preoperative technique for diagnosis of head and neck 
masses;18, 40 however, a known pitfall of FNA is its lower diagnostic rate. For thyroid lesions, 
approximately 14% and 15% of non-diagnostic and indeterminate diagnoses respectively 
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have been reported for FNA, respectively.115 This is in keeping with the results of the 
assessment of salivary gland masses, axillary lymph node metastases, and primary breast 
tumours.96, 116, 117 
FNA success is dependent on two vital independent variables: specimen acquisition and 
specimen interpretation.118 Acquisition of adequate material is paramount for subsequent 
diagnostic and ancillary testing to obtain results. As FNA is a technical skill, practice, sufficient 
procedure volume, and continuing education regarding FNA techniques is critical for high 
quality specimen acquisition.118 Operator experience has been found to affect the non-
diagnostic rate of FNA.119, 120 In a study by Ljung et al, 314 aspirates were performed by 69 
physicians without formal training with median experience of 2 FNAs a year found a 
nondiagnostic rate of 36.9% versus 2.2% for 729 aspirates performed by 7 formally trained 
physicians with at least 100 FNAs per year experience.119 Ghofrani et al demonstrated that 
the ultrasound guided FNA non-diagnostic rate was 8.2% in less experienced radiologists and 
5.4% in the experienced radiologist group, this difference was not statistically significant.120 
Rapid onsite evaluation (ROSE) of the aspirate by a trained cytologist has been 
recommended for real-time feedback to ensure adequate specimen acquisition. A meta-
analysis conducted by Witt and Schmidt found that adequacy rate without ROSE for salivary 
gland aspirates was 83% compared to 92% with ROSE.121 This was found to be dependent 
on the initial inadequacy rate of the centers, with centers with lower initial adequacy rates 
benefitting the most from implementation of ROSE.121 Core needle biopsy being a 
mechanically operated technique performed by trained interventional radiologists is being 
explored to curb the inadequate and inconclusive results of FNA. Core needle biopsy 
provides larger and better architecturally preserved tissue that allows assessment with 
molecular testing and immunohistochemical staining.     
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The caveat to the superiority of CNB is the reported higher post procedure complication risk in 
some studies.117 CNB being a slightly more invasive technique, has increased theoretical risk 
of using a larger bore needle. The pertinent risks include vascular or parotid facial/recurrent 
laryngeal nerve damage, and displaced epithelia and tumour seeding.109 A systematic review 
assessing CNB accuracy for salivary tumours reported an overall haematoma rate of 1.7%96. 
A recently published meta-analysis that evaluated types and incidence of complications 
associated with CNB in diagnosis of thyroid nodules reported a pooled complication rate of 
1.11%, with pooled major complication rate being much lower (0.06 %) than minor 
complications (1.08%).104 A systematic review of complications post FNA reported a similar 
risk profile for FNA.103 Most complications following FNA and CNB are transient, have low 
morbidity and are self-limited: the overall safety of FNA and CNB appears to be 
comparable.104 
It is important to determine the accuracy of ultrasound guided CNB compared to ultrasound 
guided FNA in its ability to provide adequate tissue to obtain a pathological diagnosis. Timely 
indentification of malignancy allows for prompt treatment whilst correct identification of benign 
tumours avoids unnecessary diagnostic surgery and the associated patient anxiety, 
complications and healthcare costs. The potential advantages and disadvantages of each 
technique raise questions about the relative roles of each technique in the diagnosis of head 
and neck masses. Should CNB be used first instead of FNA or should it be reserved for 
situations when FNA cytology is inadequate or inconclusive? A head to head comparison of 
diagnostic accuracy of FNA and CNB is necessary to help address these questions. The 
objective of this systematic review was to compare the diagnostic accuracy of ultrasound 
guided CNB and ultrasound guided FNA in the diagnosis of malignant and neoplastic head 
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and neck nodules, through meta-analysis of data from two arm prospective and retrospective 
studies.  
Systematic reviews have become a cornerstone of evidence-based medicine and provide the 
basis for policy making and clinician and patient decision making. Several studies have 
attempted to analyse the accuracy of FNA and CNB individually, but a diagnostic assessment 
by comparison of CNB and FNA has not been summarised in a meta-analysis for head and 
neck masses. PROSPERO, MEDLINE, the Cochrane Database of Systematic Reviews and 
the JBI Database of Systematic Reviews and Implementation Reports were searched and no 
current or underway systematic reviews on the topic were identified.  The objective of this 
review was to determine the difference in diagnostic accuracy of CNB and FNA for patients 
with a head and neck mass using surgical histopathology as a reference test and compare 





Systematic reviews are at the cornerstone of evidence-based medicine providing an overview 
of the relevant literature in a systematic and transparent way. Systematic reviews explicitly 
describe the origin of their study base and the reasons for selection of included studies.39 A 
thorough methodological quality assessment is performed, and if appropriate, the results are 
summarised quantitatively in a meta-analysis. The robust methodology aims to limit and 
recognise bias, and improve the reliability of conclusions.2 Additionally, systematic reviews 
help us verify whether findings are consistent and can be generalised to various situations.39 
Diagnostic tests help clinicians develop management plans by identifying presence or 
absence of a condition in a patient.26 Common diagnostic tests include signs and symptoms 
observed when taking a history or performing a clinical exam, biochemical and imaging 
technologies, and psychological interventions.23 To address the ongoing need for faster, cost-
effective tests, that are easy to perform, and are safe and accurate, new tests are being 
developed continuously.26 Subsequently, at any given time there are multiple tests available 
to diagnose a particular condition. This has resulted in a growing demand for high level 
evidence on accuracy of diagnostic tests to improve patient outcomes. Systematic reviews of 
effectiveness consider if diagnostic tests improve outcomes. Systematic reviews of diagnostic 






Systematic reviews and meta-analyses of diagnostic test accuracy are a relatively new 
addition to evidence-based medicine. The decision to include this methodologically 
challenging review type in the Cochrane Group was made in 2003, ten years after The 
Cochrane Collaboration was founded.25  The first diagnostic accuracy review was published in 
October 2008 a year after the Cochrane Library was ready to register DTA reviews.39 This 
delay has been mainly attributed to slow methodological development and difficulty 
synthesising results of diagnostic studies, resulting in narrative summaries as opposed to 
meta-analyses.39 At the time of writing seven out of 11 chapters of the Cochrane Handbook 
for Systematic Review for DTA are incomplete. Low quality of included studies, inadequate 
reporting resulting in an inability to assess the quality of included studies tarnish many 
systematic reviews of diagnostic test accuracy.23, 26, 28, 35 
The objectives, inclusion criteria and methods of analysis for this review were specified in 
advance and documented in an a priori published protocol.  
Soumya, Whitehorn A, Ooi EH, Lockwood C. Accuracy of core needle biopsy compared to 
fine needle biopsy for the diagnosis of neoplasm in patients with suspected head and neck 
cancers: a systematic review protocol of diagnostic test accuracy. JBI Database System Rev 
Implement Rep. 2020. 
2.1 Inclusion Criteria 
2.1.1 Participants  
The review considered adults (above age 18 years) presenting with a head and neck lesion 
for investigation. All studies with paediatric patients were excluded, as head and neck lumps 
in children are often of infectious or congenital aetiology18 and are generally not subjected to 
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investigation with FNA or CNB.  In addition, paediatric patients that do undergo tissue 
sampling have altered techniques e.g. FNA under local anaesthetic or lack of excisional 
biopsy as a reference test.122 Patients of all genders were included. Studies with patients with 
a suggestive history and physical examination of a head and neck lesion with or without 
formal imaging were included.  
2.1.2 Index test  
This review included studies that compared the diagnostic accuracy of ultrasound-guided 
CNB and ultrasound-guided FNA as the index test of interest. While needle biopsy can be 
conducted by palpation, studies have demonstrated a higher diagnostic yield for image-
guided (ultrasound or CT) biopsy.68-70 Therefore, studies that did not specifically state the use 
of ultrasound were excluded. 
For categorisation of neoplasm, the results were recorded as positive if the index test 
diagnosis was neoplastic, malignant, atypical, or suspicious, and recorded non-neoplastic 
results as negative. For analysis of malignancy, malignant, suspicious results were recorded 
as positive; benign, atypical and non-neoplastic results were recorded as negative. 
Indeterminate was defined as atypia of undetermined significance (AUS) or follicular lesion of 
undetermined significance (FLUS) or follicular neoplasm or suspicious for follicular neoplasm. 
Prior to the introduction of the Bethesda, some studies classified indetermediate results as 
benign increasing the false negative rate while other studies classified them as malignant 
increasing the false positive rate.123, 124 In our review, the rate of indeterminate or inadequate 
results were recorded and compared where possible. 
All studies that used 21- 28-gauge needles for FNA and 16-20-gauge needles for CNB were 
included. Where available methodological description was recorded to assess if diagnostic 
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accuracy was affected by sample collection method, preparation and interpretation. Needle 
size, number of passes, clinical background and experience of the person performing the 
biopsy (radiologist, pathologist, clinician), availability of onsite assessment of adequacy by 
cytopathologist/pathologist, and experience of pathologist analysing the sample were 
recorded. In addition, where available, the device used for CNB and use of 
immunohistochemical and histochemical stains was recorded. 
2.1.3 Reference test  
The primary reference standard was the final surgical histopathology in the form of neck 
dissection, parotidectomy, thyroidectomy, or excisional biopsy. The reference test result was 
deemed positive if found to be neoplastic for neoplasms or malignant for assessing 
malignancy, and negative if non-neoplastic. Patients that have a negative index test generally 
do not undergo surgical excision as it is invasive and often unnecessary if the condition is 
benign. In such cases, where available, long term clinical follow up was used as a reference 
standard (minimum 1 year).   
2.1.4 Diagnosis of interest 
Lesions of the head and neck broadly categorised as non-neoplastic, benign and malignant 
were the target diagnoses of interest. The accuracy of two diagnoses were assessed in this 
review 1) neoplastic versus non-neoplastic and 2) malignant versus non-malignant.  
2.1.5 Types of studies  
This review considered two-armed studies that compared the accuracy and/or complications 
of ultrasound-guided FNA and CNB for the diagnosis of lesions of the head and neck. 
Included studies had extractable accuracy data including true positives (TP), false positives 
(FP), false negative (FN) and true negatives (TN) either as group totals, case by case 
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indexing of diagnoses or provided raw data that allowed for calculation of TP, FP, FN, and TN 
Table 8 shows an example of classification of TP, FP, FN, TN.  
Studies were not limited by publication type, year of publication, language, location or setting. 
Studies published in English were included. Studies published in foreign languages were 
excluded at the full-text review stage, but their title pages are presented in the Appendix I of 
this review. The studies described number of patients that received FNA and CNB, and the 
number of patients that were referred to the specific type of follow up (medical versus 
surgical) and the outcomes for each group. 
This review considered both experimental and quasi-experimental study designs, including 
randomized controlled trials, non-randomized controlled trials, before and after studies and 
interrupted time-series studies. In addition, analytical observational studies including 
prospective and retrospective cohort studies, case-control studies and analytical cross-
sectional studies were considered for inclusion. Conference abstracts were excluded as no 
extractable data was available and not enough information regarding the methodology and 
patient selection was available to critically appraise the study.  
Table 8 Description of patient classification for diagnostic test accuracy of FNA for 
malignancy 
Patient classification Description of test result 
True positive Positive FNA result 
Positive final histopathology result 
True negative Negative FNA result 
Negative final histopathology result 
False positive Positive FNA result 
Negative final histopathology result 
False negative Negative FNA result 
Positive final histopathology result 
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Positive FNA result = suspicious for malignancy/malignancy 
Negative FNA result = benign, non-neoplastic, atypical, AUS/FLUS, FN/Suspicious for 
follicular neoplasm.  
2.2 Search strategy  
The search strategy aimed to locate both published and unpublished studies. An initial limited 
search of MEDLINE was undertaken to identify articles on the topic. The text words contained 
in the titles and abstracts of relevant articles, and the index terms used to describe the articles 
were used to develop a full search strategy for MEDLINE (see Appendix II). The search 
strategy, including all identified keywords and index terms, were adapted for each included 
information source using Polyglot Search Syntax Translator.125 The reference lists of all 
studies selected for critical appraisal were screened for additional studies.  
2.3 Information sources  
The databases that were searched included MEDLINE, EMCARE, EMBASE, Web of Science, 
Cochrane library. Sources of unpublished studies and grey literature included the TRIP 
database, the National Institute of Health and Care Excellence (NICE), and Evidence-Based 
Medicine Reviews (EBMR) to retrieve evidence-based resources relevant to this systematic 
review, the reference lists of grey literature were also scanned for additional studies. 
2.4 Study selection  
Following the search, all identified citations were collated and uploaded into EndNote X9 
(Clarivate Analytics, PA, USA) and duplicates removed.126 Covidence was used to screen 
titles and abstracts by two independent reviewers for assessment against the inclusion criteria 
for the review.127 Potentially relevant studies were retrieved in full and their citation details 
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imported into the Joanna Briggs Institute System for the Unified Management, Assessment 
and Review of Information (JBI SUMARI) (Joanna Briggs Institute, Adelaide, Australia).128 
The full text of selected citations was assessed in detail against the inclusion criteria by two 
independent reviewers. Reasons for exclusion of full text studies that did not meet the 
inclusion criteria were recorded and reported in the systematic review. Any disagreements 
that arose between the reviewers at each stage of the study selection process were resolved 
through discussion. The results of the search were reported in full in the final systematic 
review and presented in a Preferred Reporting Items for Systematic Reviews and Meta-
analyses (PRISMA) flow diagram.129, 130 
2.5 Assessment of methodological quality  
Studies that met the inclusion criteria were critically appraised by two independent reviewers 
for methodological quality using the signaling questions from the standardized critical 
appraisal instrument QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) tool. 
131 The QUADAS-2 tool incorporates reviewers concerns regarding the applicability of 
included studies, this element of QUADAS-2 was not included in this review as research 
studies that did not meet the inclusion criteria or studies that did not answer the research 
question did not proceed to the critical appraisal stage. Any disagreements that arose were 
resolved through discussion.  
2.6 Data extraction  
Data was extracted from papers included in the review using the standardized data extraction 
tool available on JBI Reviewers Manual: JBI Diagnostic Accuracy Test Assessment and 
Review Instrument by two independent reviewers (Appendix IV).132 The data extracted 
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included specific details about the tests, populations, study methods and outcomes of 
significance to the review question and specific objectives. Test accuracy results were 
recorded in a 2x2 table (Table 9) adapted from Macaskill et al133 Any disagreements that 
arose between the reviewers were resolved through discussion.  
Table 9 An example for 2x2 data extraction table to classify test results and disease 
status 
Test outcome (CNB 
results) 
Disease/condition status (final histopathology results) 
Malignancy positive Malignancy 
negative 
Total 
CNB positive True positives (a) False positives (b) Test positives (a+b) 







The sensitivity and specificity were calculated using the data from Table 9. 
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =  𝑎 ÷ (𝑎 + 𝑐) 
𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦 =  𝑑 ÷ (𝑏 + 𝑑) 
2.7 Data synthesis  
Analyses were performed using a meta-analysis of diagnostic accuracy by fitting a bivariate 
mixed-effects logistic regression model. All systematic reviews of diagnostic accuracy 
inherently have significant heterogeneity in between studies. Pooled proportions for non-
diagnostic and inconclusive specimens were determined using a random-effects model, which 
incorporates an estimate of between study variation (heterogeneity) in the weighting for 
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calculation of summary statistics.133 The random effects model describes the variability in test 
accuracy across studies and estimates the average accuracy of the tests.  
Results are presented as Summary Receiver Operating Characteristics (SROC) curves, 
forest plots and estimated summary sensitivity, specificity, positive and negative likelihood 
ratios, and area under the SROC curve with 95% confidence intervals (CI). Heterogeneity 
among the studies was assessed by the Cochran Q and the I2 statistics. The Q statistic was 
defined as the weighted sum of squared deviations of the estimates of all studies; p < 0.05 
was considered statistically significant for heterogeneity. An I2 statistic >50% indicated 
heterogeneity.  
All analyses were performed using Stata v15 (College Station, TX, USA)134. Diagnostic 
accuracy meta-analyses were performed using the user-written package midas.135 Pooled 
estimates for non-diagnostic and inconclusive specimens were performed using the Stata 
package metan.136  
2.8 Assessing confidence  
A 'summary of findings' table was created using GRADEPro GDT software. The GRADE 
approach for grading the quality of evidence for diagnostic test accuracy was followed.137  The 
following outcomes were included in the 'Summary of Findings' table: index test outcomes: 
non-neoplastic, inadequate, indeterminate, benign, suspicious/atypical, malignant; reference 










3.1 Search results 
The search for relevant studies was conducted in May-June 2019 with assistance from an 
experienced research librarian. The search strategy detailed in Appendix II was tailored and 
used to search the databases mentioned in ‘Methodology’ section 2.3. A total of 3999 
potentially relevant titles were identified by the primary author. The number of duplicates 
excluded were 1426. Duplicates were identified and removed using EndNote126 and 
Covidence127 followed by manual searching and removal of remaining duplicates. Titles, 
keywords and abstracts of 2575 potentially relevant articles were screened in Covidence 
(108) against the inclusion criteria by two independent reviewers (AW and SS), any 
disagreements were resolved through discussion.(144) At the title/abstract search stage, 
2422 papers were excluded as they were irrelevant or did not meet inclusion criteria , and 149 
were retrieved for full text examination to assess eligibility for inclusion. Following full text 
review, 140 studies were excluded by two independent reviewers (AW and SS), any 
disagreements were resolved by discussion and involvement of third reviewer (CL). Figure 1 
details the study identification process. Finally, nine studies were included in the systematic 
review of which six studies were included in the meta-analysis. 
The most common reasons for exclusion at the full text review stage included (Appendix V): 
• The study focused on sensitivity/specificity data of one of the tests only, for example 
fine needle aspiration with no comparison to core needle aspiration (n=30) 
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• Conference abstracts were excluded due to lack of adequate demographic data to 
assess for eligibility or lack of index test details to assess methodological quality or 
lack of extractable data (n=23) 
• Literature reviews/editorials discussing diagnostic accuracy of core needle biopsy and 
fine needle aspiration (n=16) 
• The study did not have a histopathological surgical comparator i.e. study reference test 
(n=15) 
• Unclear or lack of ultrasound guidance for fine needle aspiration (n=13) 
• Inclusion of paediatric patients in analysis (n=13) 
• Many studies of lymph nodes did not report data specific for head and neck region, e.g. 






Figure 1 Study selection process(140) 
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3.2 Methodological quality 
Assessment of the quality of the included studies was performed using the JBI modified 
QUADAS-2 tool (Table 10). The QUADAS-2 work group have identified two important 
components that constitute quality of a diagnostic study a) avoidance of ‘risk of bias’, as well 
as b) concerns regarding ‘applicability’.131 JBI recommends the use of QUADAS-2 and 
includes the signaling questions in the appended checklist (Appendix III).138 However, 
concerns regarding applicability are omitted in this checklist as a primary study should not 
proceed to critical appraisal if there was concern regarding its inclusion criteria or research 
question.138 Four key domains are assessed in the QUADAS-2 tool - patient selection, index 
test, reference standard, and patient flow through the study and the timing of the index test 
and reference standard.  
Table 10 JBI Critical Appraisal Checklist for Diagnostic Test Accuracy Studies(115) 
Q1 Was a consecutive or random sample of patients enrolled? 
Q2 Was a case control design avoided? 
Q3 Did the study avoid inappropriate exclusions? 
Q4 Were the index test results interpreted without knowledge of the results of the reference 
standard? 
Q5 If a threshold was used, was it pre-specified? 
Q6 Is the reference standard likely to correctly classify the target condition? 
Q7 Were the reference standard results interpreted without knowledge of the results of the 
index test? 
Q8 Was there an appropriate interval between index test and the reference standard? 
Q9 Did all patients receive the same reference standard? 
Q10 Were all patients included in the analysis? 
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The overall quality of the included studies was moderate. The results of the critical appraisal 
are summarised in Table 11 andTable 12 and Figure 2. No studies were assessed to be at 
low risk of bias in all four domains. Two studies were at high risk of bias in the patient 
selection domain. Bias associated with domains of index test and reference test could not be 
assessed due to inadequate reporting in the included primary studies. Flow and timing was 
the domain most susceptible to bias. 
Table 11 Methodological quality assessment using QUADAS-2 
 Patient selection Index test Reference test Flow and timing 
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 
Choi 2014 Y Y Y U NA Y U U N N 
Harvey 2005 U Y Y Y NA Y U U N Y 
Karstrup 2000 Y Y Y Y NA Y U U N N 
Novoa 2015 U Y U Y NA Y Y U N Y 
Pisani 2000 N Y Y Y NA Y U U N N 
Sung 2012 Y Y Y U NA Y U U N Y 
Trimboli 2014 N Y Y Y NA Y U U Y Y 





Table 12 Summary of Risk of Bias Assessment 
Study RISK OF BIAS 
PATIENT 
SELECTION 
INDEX TEST REFERENCE STANDARD FLOW AND TIMING 
Harvey 2005 ?  ?  
Karstrup 2000   ?  
Yi 2015     
Novoa 2015 ?    
Pisani 2000   ?  
Trimboli 2014   ?  
Sung 2012  ? ?  
Choi 2014 ? ? ?  
 





Figure 2 Risk of bias 
3.2.1 Patient Selection  
Most studies described that the patients were enrolled consecutively or that all cases within a 
particular period were included (7/9).123, 124, 139-143 However, the selection criteria for allocation 
of patients to CNB versus FNA was not clearly described in Harvey et al, Pisani et al, Trimboli 
et al, and Choi et al.123, 140, 141, 143 It is difficult to ascertain if the patients selected for CNB in 
these studies are representative of all patients with neck masses that may have ordinarily 
been selected for FNA as there was no randomised allocation of participants to receive CNB 
versus FNA in these studies. 





















In Yi et al144, it seemed likely that consecutive cases were included; however, it was not 
clearly stated. In Novoa et al88, the selection criteria were not clear. 
All the included studies avoided a case-control study design. All studies avoided inappropriate 
exclusions. The overall risk of bias was assessed to be low for patient selection in most 
studies 8/9.123, 124, 139-144 Novoa et al reported patient selection poorly, adequate 
methodological assessment of patient selection was not possible, and risk of bias could not 
be assessed.     
3.2.2 Index Test  
None of the studies explicitly stated that the cytologist/histopathologist interpreting FNA and 
CNB were blinded or unaware of the reference standard except Yi et al.144 However, the 
index test (FNA or CNB) is generally the predictor of the reference standard (surgical 
histopathology/follow up), one could assume that FNA and CNB results were interpreted 
without knowledge of the results of the reference standard. As the majority of the studies were 
retrospective the risk of bias could not be assessed for question 4 for the index test domain. 
In one retrospective study, the cytology/histopathology results of FNA and CNB were ‘re-
classified’ according to the Bethesda 2009 system.142 There was no mention of blinding of the 
pathologists to the reference standard when this reclassification was conducted. This 
introduces a potential for bias if the pathologist interpreting the index test was aware of the 
reference standard result.  
There was no pre-specified threshold used in any of the included studies, this component was 
therefore not applicable to the methodological quality assessment 
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3.2.3 Reference Standard  
Histopathological examination of the surgical specimen was the reference standard used to 
correctly classify malignancy for all included studies. A positive FNA or CNB result is an 
indication for surgical excision, the specimen is then stained for confirmation of diagnosis and 
staging.66 This reference standard may be imperfect and may give rise to misclassification 
errors, but there is no literature on the error rate of histopathological diagnosis. 
For patients that were found to have a benign result or were not surgical candidates, most 
studies considered clinical and sonographic follow up as the reference standard. Both these 
reference standards were deemed appropriate for all studies. The differential verification 
introduces a partial verification bias, as the two reference standards probably have a varying 
error rate. However, there is no suitable reference test that can be applied to both groups.145  
Generally, the pathologist is aware of the FNAC and CNB findings when interpreting surgical 
specimens, but the histopathological specimens are weighted more than FNA and CNB 
findings. Although the results of FNA and CNB influence the final diagnosis, this influence is 
not likely to be significant enough to alter the histopathological diagnosis. There was an 
unclear risk of bias for the conduct of index tests. Novoa et al and Yi et al clearly stated that 
the pathologist was blinded to reduce information bias while interpreting the reference test 
and were scored positively.  
3.2.4 Flow and Timing  
No studies specifically mentioned the time interval between FNA/CNB and histological 
evaluation, possibly leading to timing bias. Generally, if surgery is indicated, it is performed 
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relatively soon after the index test, we believe that the interval between the index tests and 
examination of the surgical specimen is unlikely to be long enough for the tumour to 
significantly change and produce false negative results. This item for time interval between 
the index test and reference test was marked unknown for all studies 
The patients did not receive the same reference standard in most of the studies as it is not 
standard practice for all patients with benign index test results to have surgical intervention 
(7/8).88, 123, 124, 140, 142-144 Only Trimboli et al used final histological exam as the reference 
standard for all patients.141 In all included studies, histological verification was used for 
malignant FNA and CNB results. Varying proportions of patients with benign pathology were 
followed up sonographically and clinically across the included studies. Differential verification 
of FNA and CNB also poses a problem as generally reference standards differ in accuracy 
(histopathology of a nodule vs follow-up for detection of malignancy) and this affects the 
diagnostic test accuracy introducing a risk of bias.  
Not all studies included all patients in the analysis. Karstrup et al compared FNA and CNB 
results to the histological surgical diagnosis for 41 patients but did not describe the follow 
up/results for the remaining 36 patients.124 Yi et al did not account for 59 patients that were 
not included in the final analysis due to lack of final diagnosis.144 Pisani et al did not describe 
any follow up details for 95/136 patients that did not have a histological diagnosis.140 Choi et. 
al did not verify results for 52/180 patients for CNB and 40/180 patients for FNA.143 Exclusion 
of patients at the analysis stage without an explanation introduces a partial verification bias as 




3.3 Description of studies 
Data collected included setting (outpatient vs inpatient), period of study, location (country), 
study design (prospective vs retrospective), study type (cross-sectional case-study vs cross-
sectional cohort) population characteristics (age, gender), method (experience of pathologist, 
availability of onsite cytology, details of person performing the procedure, needles and 
devices used, number of passes), and the reference standard used. The detailed 
characteristics of the included studies are summarised in Table 13. The majority of the 
studies were conducted in South Korea (4 of 9). There were six retrospective and three 
prospective studies. The studies were generally unclear on the setting of the FNA and CNB.  
Of the nine included studies eight focused on the diagnostic accuracy of FNA and CNB for 
thyroid nodules123, 124, 139-144, the remaining study assessed salivary gland masses.88 The 
study by Novoa et al was not included in the meta-analysis as it would be inappropriate to 
pool sensitivity of one study assessing salivary gland pathology with eight studies focusing on 
thyroid nodules. A total of six studies had diagnostic accuracy data related to thyroid 
malignancy. There was not adequate raw data available for pooling of sensitivity and 




Table 13 Characteristics of included studies 















Thyroid Initial FNA non-
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to rate their pain 
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Patient demographics and index test characteristics are summarised in Table 14. The studies 
recruited a total of 2061 patients, with mean (or median) age ranging from 44.4 to 54.4 years. 
The proportion of male patients ranged from 13.7 to 23% for all studies except Novoa et al 
where salivary gland nodules were more common in men (54%). 
All nine studies used ultrasound guidance for both FNA and CNB.20, 123, 124, 139-144 Harvey et al 
included 266 patients that underwent FNA, only 59 of these patients underwent aspiration 
under ultrasound guidance.123 Only the ultrasound guided results were included in the meta-
analysis. FNA was performed using 21 - 25 gage needles in one to three passes. For CNB, 
the biopsy procedures were generally performed using 18 - 21 gauge (G) core needles, with 
the majority of the studies using 18G needles123, 124, 139, 142-144 with one to four passes. Five 
studies specified that the sample was obtained by a radiologist124, 139, 142-144, one study 
indicated that specimens were obtained from non-pathologists (surgeons, endocrinologist, or 
radiologist)123, one study specified that the sample was obtained by a surgeon141, one study 
had two experienced sonographers obtaining specimens88 and one study did not specify who 
obtained the sample.140 The experience of radiologists ranged from 5-17 years and was well 
documented in four studies.124, 142-144 Only two studies reported the experience of the 
pathologist in years.142, 144 
Novoa et al had onsite cytology available for FNA.88 The accuracy rate and non-diagnostic 
rate of FNA for these participants may be higher due to this provision. Choi et al assessed 
sample adequacy crudely by visual inspection and re-aspirated nodules with less than six 
particles.143 The use of immunohistochemistry is likely to improve the inconclusive and non-
diagnostic percentage of FNA and CNB.121 Only Novoa et al and Trimboli et al explicitly 
reported the use of immunohistochemistry.88, 146  
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Table 15 describes the characteristics of the nodules and the reference standard details. The 
mean nodule size ranged from 12.8 – 16.2 mm in diameter with the majority of the nodules 
being solid.  Jeong et al139 Pisani et al140, Novoa et al88 and Yi et al144 did not describe the 
characteristics of the nodules.  Karstrup et al124, Yi et al144 and Choi et al 143 failed to account 


































Malignant final diagnosis based on the surgical 
specimen (n=72,26.9 %). A final diagnosis of 
benign nodule was made in196 nodules (73.1 
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42 patients underwent surgery; all the patients 
with benign result were followed up clinically 
and sonographically and did not demonstrate 
increase in nodule size. No clear indication of 
how follicular neoplasms were managed.  
Sung 
2012142 




526 solid, 26 
predominantly 
solid and 3 
cystic 
Malignancy 555 Final diagnosis of malignant nodules was 
determined by surgical resections (318); 
benign diagnosis (237)  
surgical (n=41,17.3%)  
repeated benign readings on FNA/CNB (at 
least 2) (n=35,14.8%)  
benign FNA/CNB and decrease in maximal 
diameter of >50% at follow up (n=6, 2.5%)   
concordant FNA and CNB and clinical follow 
up of at least 1 year (n=155, 65.4).  
Trimboli 
2014141 
41 31 11.5 All nodules 
were solid 
Malignancy 72 (FNA-
41; CNB – 
31) 
Final histological examination (FNA n=41 and 
CNB n = 31) 
Yi 
2015144 
147 147 NR NR Malignancy 86 Histopathological results after surgery (n=32) 
or a benign diagnosis based on:  
repeated benign readings on FNA (at least 2) 
(n=11, 20.4%)  
benign FNA/CNB and stable size at follow up 
>1 year (n=13, 24.1%)  






3.4 Findings of the review 
3.4.1 Diagnostic accuracy of CNB and FNA for diagnosing salivary gland lesions - 
Novoa et al88 
Only one study comparing the accuracy of FNA and CNB for salivary gland tumours met this 
systematic review’s inclusion criteria. A total of 108 patients listed for salivary gland surgery 
based on FNA were prospectively recruited and CNB was performed under general 
anaesthetic immediately before surgical excision for 100 patients. Novoa et al found that CNB 
detected malignancy and true neoplasms in salivary gland lesions with a sensitivity of 95% 
and 98% respectively as compared to 64% and 94% for FNA.88 Table 16 describes the results 




Table 16 Diagnostic accuracy of CNB and FNA for diagnosing salivary gland lesions - 
Novoa 201688 
Study Method Tissue 
type 










































3.4.2 Complications for salivary gland lesions – Novoa et al88 
Novoa et al was the only study to include salivary gland lesions and did not note any 
bleeding, major hematomas, local infections, or nerve injuries in their study. Participants in 
this study ceased antiplatelets and anticoagulants for one week prior to the biopsy where 
possible. CNB and FNA was performed on three patients that could not cease antiplatelets. 
Six patients had FNA with bridging unfractionated heparin ceased four hours prior to the 
procedure, one patient was on low-molecular weight heparin while FNA was performed.  
Novoa et al examined needle tracks in the surgical specimen for all the patients that 
underwent surgical excision, no tumour seeding was noted in 63% of the cases, and the 
needle track could not be identified in 37% of the patients. All patients were followed up 
clinically and sonographically for up to six years and did not demonstrate tumour recurrence. 
3.4.3 Diagnostic accuracy of CNB and FNA for diagnosing thyroid malignancy 
The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) was used to classify 
nodules from category 5 (suspicious for malignancy) and category 6 (malignancy) as 
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malignant. Category 1 (non-diagnostic) results were not included in the analysis of 
malignancy. Six studies compared the diagnostic accuracy of 1118 patients for FNA and 1024 




Table 17 Details of the studies included in meta-analyses 
Study Method Tissue 
type 













FNA Malignancy 13 2 7 62 65 97 40 33 23 
CNB Malignancy 45 0 1 80 98 100 1 8 36 
Harvey 
2005123 
FNA Malignancy 3 0 1 31 75 100 41 8 11 
CNB Malignancy 4 0 2 63 67 100 13 11 8.7 
Karstrup 
2000124 
FNA Neoplasm 15 5 3 17 83 77 3  45 




FNA Neoplasm 22 3 1 16 96 84 4 10 54 
CNB Neoplasm 6 0 0 10 100 100 41 13 35 
FNA Malignancy 10 0 3 29 77 100 4 10 31 
CNB Malignancy 3 0 2 11 60 100 41 13 31 
Sung 
2012142 
FNA Malignancy 218 0 84 219 72 100 6 19 58 
CNB Malignancy 276 2 36 233 88 99 1 13 57 
Trimboli 
2014141 
FNA Malignancy 30 0 3 7 91 100 2 17 82 
CNB Malignancy 24 0 0 6 100 100 3 0 80 
Yi 
2015144 
FNA Malignancy 23 0 7 43 77 100 27 16 41 




Table 17 shows the performance data for the diagnosis of thyroid malignancy from included 
studies. Table 18 shows the accuracy estimates for each diagnosis method. The SROC curve 
for diagnosis of malignancy is shown in Figure 3a and 3b. The area under the SROC curve 
was larger in CNB than in FNA (1.00; 95% CI 0.99 to 1.00 vs. 0.88; 95% CI 0.85 to 0.91) 
(Figure 3). 
Figures 4 and 5 show the forest plots for the sensitivity and specificity for FNA and CNB. CNB 
demonstrated a summary sensitivity of 91% (95% confidence interval [CI] 79% to 96%) and 
specificity of 99% (95% CI 98% to 100%); and FNA demonstrated a summary sensitivity of 
75% (95% CI 66% to 83%) and specificity 100% (95% CI 60% to 100%). There was no 
significant difference between the summary estimates of sensitivity (p = 0.125) or specificity 
(p = 0.806). There was more variability in sensitivity than specificity.  
Table 18 Comparison of accuracy data for CNB Vs FNA for diagnosis of malignancy 
 Sensitivity (%) Specificity (%) 










(n = 6) 
73.0 75 (66 
– 83) 
(n = 6) 
29.6 0.125 100 (98 
– 100) 
(n = 6) 
0.0 100 (60 
– 100) 













Figure 3 Summary ROC curves with confidence and prediction regions around mean 






Figure 4 Forest plot study specific and mean sensitivity and specificity with 





Figure 5 Forest plot study specific and mean sensitivity and specificity with 
heterogeneity statistics for CNB 
 
 A wide range of heterogeneities were found in the summary sensitivity and specificity: 
Sensitivity: CNB I2 =  73.0 (Q = 18.5; df = 5; p < 0.001), FNA I2 = 29.6 (Q = 7.10; df = 5; p = 
0.210); Specificity: CNB I2 = 0.0 (Q = 2.38; df = 5; p = 0.790), FNA I2 = 56.0 (Q = 11.37; df = 
5; p = 0.04). Tests for study heterogeneity were not significant for either FNA (Q = 1.95; df = 
2; p = 0.189) or CNB (Q = 0.09; df = 2; p = 0.477). 
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3.4.4 Incidence of the non-diagnostic and inconclusive CNB and FNA 
results 
Table 19 shows the summary of the pooled proportions of the non-diagnostic and 
inconclusive CNB and FNA results. The non-diagnostic CNB results demonstrated a pooled 
proportion of 4.3% (95% CI 1.6 to 7.0%), and the non-diagnostic FNA results demonstrated a 
pooled proportion of 16.4% (95% CI 8.3 to 24.5%). The inconclusive CNB results 
demonstrated a pooled proportion of 11.2% (95% CI 8.7 to 13.7%), and the inconclusive FNA 
results demonstrated a pooled proportion of 17.0% (95% CI 10.6 to 23.3%). These results 
demonstrate that the proportion of non-diagnostic and inconclusive CNB results was 
significantly lower than FNA (p < 0.001). Considerable heterogeneity was found in the pooled 
proportion of non-diagnostic and inconclusive CNB and FNA results (I2 = 57.9 to 96.6%). 
Figure 6 shows the forest plots for the non-diagnostic and inconclusive CNB and FNA results. 
 
Table 19 Summary of the pooled proportions of the non-diagnostic and 
inconclusive CNB and FNA results 
 Non-diagnostic results (%) Inconclusive results (%) 
 CNB I2 % FNA I2 % P 
value 









































No major complications were reported in any of the included studies. Out of eight studies, 
three studies described one postoperative haematoma (Table 20), two episodes of 
haemorrhage and one incident of parenchymal oedema were reported after CNB. Only one 
patient required hospitalisation for overnight monitoring post a perithyroidal haemorrhage. No 
complications were reported for FNA in these studies. As patients of four included studies had 
simultaneous FNA and CNB procedures the complications could not be attributed to a single 
procedure.124, 142, 144 In these studies, 19 cases of perithyroidal haematoma and 13 cases of 
parenchymal oedema were reported. Sung et al did not note any cases of infection or needle 
track seeding during the follow up period.124, 142, 144        
Table 20 Complications of FNA and CNB 
 
FNA CNB Simultaneous FNA and CNB 
Perithyroidal haemorrhage Nil reported 2 Nil reported 
Perithyroidal haematoma Nil reported 1 19 
Parenchymal oedema Nil reported 1 13 
  
Six studies described manual compression of the biopsy site after FNA/CNB procedures.88, 
124, 139, 142-144 The time for manual compression ranged from 5 minutes to 30 minutes. Trimboli 
et al and Sung et al ceased antiplatelets and anticoagulants for one week prior to the biopsy 
where possible.141, 142 The remaining studies did not describe antiplatelet/anticoagulation 
management in their methods.    
Jeong et al did not find a statistically significant difference in pain scores during and at 20 
minutes after FNA and CNB (3.7 vs. 3.6, P= 0.454; 0.9 vs. 1.1, P = 0.296, respectively).139 
73 
 
The study did not demonstrate any difference in tolerability and complications between the 







4.1 Summary of main results 
The main results of this systematic review are presented in summary of findings tables (Table 
20 and 21). The objective of this review was to systematically identify and review two arm 
prospective and retrospective studies to report and compare the complications and accuracy 
of ultrasound guided CNB and FNA in the diagnosis of malignant and neoplastic head and 
neck masses. Nine studies conducted in five different countries reporting on the diagnostic 
accuracy and/or complications of FNA and CNB met our inclusion criteria.  
The results of the meta-analysis suggest that CNB appears to be superior to FNA as it is 
associated with significantly fewer non-diagnostic results (4.3% vs us FNA 16.4%) and 




Table 21 Summary of findings table - Thyroid 
What is the diagnostic accuracy of ultrasound guided fine needle aspiration compared to core needle biopsy for thyroid 
malignancy? 
Patients/Population Adult patients with thyroid nodules suspected to have thyroid malignancy 
Prior testing Patients found to have a suspicious thyroid nodule on history or physical examination, euthyroid, 
131 scintigraph proven cold nodules with baseline ultrasound performed prior 
Index test  Fine needle aspiration 
Comparator test  Core-needle biopsy 
Reference standard Surgical histopathology would be the gold standard but is not routinely performed for benign 
lesions. Reference used: clinical follow up and surgical histopathology 
Studies Cross-sectional cohort studies including equally suspected patient sample (no case control 
studies) 
Methodological concerns The methodological quality was generally poor, particularly with respect to the patient selection 
and the flow and timing domains. For these domains, few studies were at low risk of bias. 
Differential verification was used in most studies because most of the participants with benign 
aspiration/biopsy results did not have surgery. Clinical follow-up for these participants was 
inadequate, incomplete, or poorly described in most studies. Uninterpretable results and 
withdrawals poorly reported. 
Inconsistent reporting of inconclusive and non-diagnostic results. Inconclusive results often 
included in summary accuracy calculation 
Test Summary 
accuracy 













0.75 (95% CI: 






1118 (6)  36 (11-82) With a pre-test probability of 36%, 36 out 
of 100 people will have thyroid cancer. 






1.00 (95% CI: 





0.91 (95% CI: 
0.79 to 0.96) 
Specificity 
1.00 (95% CI: 
0.98 to 1.00) 
1024 (6)  36.5 (8.7-80) Out of 100 people with a 36.5% 
probability of having thyroid cancer there 
would 33 people will be correctly 
identified as having thyroid cancer and 
three people with thyroid cancer will 
remain undetected with CNB.  
What is the diagnostic adequacy of ultrasound guided fine needle aspiration compared to core needle biopsy for thyroid 
malignancy and neoplasm? 
Test Summary 
adequacy 










0.164 (95% CI: 
0.083 to 0.245) 
Inconclusive rate 
0.17 (95% CI: 










Out of 100 people that have an FNA 16 
patients will have a non-diagnostic result and 
17 patients will have an inconclusive result 
⨁⨁◯◯ 
LOW 




0.043 (95% CI: 
0.016 to 0.07) 
Inconclusive rate 
0.112 (95% CI: 




Out of 100 people that have a CNB 4 
patients will have a non-diagnostic result and 
11 patients will have an inconclusive result 
Conclusion: Sensitivity and specificity of FNA and CNB for diagnosis of thyroid malignancy for FNA and CNB are high. The 




The results on this table should not be interpreted in isolation from the results of the individual included studies contributing to 
each summary test accuracy measure. These are reported in the main body of the text of the review  
 
The results describe the absolute impact of FNA and CNB in a population with a pretest probability of 36% (derived from the 
median prevalence of the included studies). If applied in a setting with a lower prevalence, the absolute number of false 
positives will increase, and the false negatives will decrease.  
Table 22 Summary of findings table - salivary malignancy 
What is the diagnostic accuracy of ultrasound guided fine needle aspiration compared to core needle biopsy for salivary gland malignancy? 
Patients/Population Adult patients with salivary tumours suspected to have a malignancy listed for a parotidectomy 
Prior testing Patients found to have a suspicious salivary gland on history or physical examination, ultrasound 
performed prior 
Index test  Fine needle aspiration 
Comparator test  Core-needle biopsy prior to surgery under general anaesthetic 
Reference standard Surgical histopathology is be the gold standard. Reference used: surgical histopathology for majority of 
the patients (100), patients not fit for surgery were followed up clinically (8) 
Studies Cross-sectional cohort study including, patient selection somewhat biased as prospective recruitment 
via surgical listing 
Methodological concerns The methodological quality was generally poor, particularly with respect to the patient selection and the 

















0.64 (95% CI: 
0.41 to 0.83) 
Specificity 
0.94 (95% CI: 





23 people (out of 100 people) have (as yet 
undetected) malignancy. 
 
Of the 100 people who take FNA test: 
- 15 people will be correctly identified as having 
malignancy (true positives) 
- However, eight people with malignancy will remain 
undetected; their “negative” test results will be 
incorrect (false negatives).  
- 72 of these people will be correctly identified as not 
having malignancy (true negatives) 
- However, 5 people will be incorrectly identified; 
their “positive” test results will suggest they have 






0.91 (95% CI: 
0.79 to 0.96) 
Specificity 
1.00 (95% CI: 
0.98 to 1.00) 
Of the 100 people who take CNB test: 
- 21 people will be correctly identified as having 
malignancy (true positives) 
- However, two people with malignancy will remain 
undetected; their “negative” test results will be 
incorrect (false negatives). 
 - 77 of these people will be correctly identified as not 
having malignancy (true negatives) 
- However, 0 people will be incorrectly identified; 
their “positive” test results will suggest they have 
malignancy (false positives). 
 
 
In our review, complication rates for both FNA and CNB were low. CNB was associated with perithyroidal haemorrhage, 
haematoma and oedema in two studies, and these were all managed conservatively and resolved spontaneously. A systematic 
review assessing CNB accuracy for salivary tumours reported an overall haematoma rate of 1.7%.96 A recently published meta-
analysis that evaluated types and incidence of complications associated with CNB in diagnosis of thyroid nodules reported a 
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pooled complication rate of 1.11%, with pooled major complication rate being much lower (0.06%) than minor complications 
(1.08%).104 A systematic review of complications post FNA reported a similar risk profile for FNA.103 Most complications 






4.2 Strengths and Weaknesses 
The stregths of this review included a thourough and transparent conduct by following the 
methodology of Joanna Briggs Institute.27 A protocol detailing the objectives, methodology for 
conduct of the review, including the inclusion and exclusion criteria was published.147 
Comprehensive all-inclusive searches were run with no filters to target diagnostic test 
accuracy studies or language or publication date. To ensure comparison of the index tests in 
the same study population, we only included studies that made direct comparisons, either by 
testing all patients using both tests and by randomising patients to different tests. Two review 
authors independently selected studies for inclusion and assessed methodological quality of 
the included studies using QUADAS - 2, as recommended by the Joanna Briggs review 
manual.138  
It is important to note some of the limitations of this review. Our review focused on the 
accuracy and safety of FNA and CNB and not their impact on patient outcomes. The primary 
advantage of FNA and CNB is early identification of malignant and neoplastic conditions 
requiring surgical intervention to reduce treatment delay and to avoid unnecessary surgery. 
Therefore, the choice of FNA and CNB will depend on the type of tumour/patients with 
malignancy or a neoplastic condition requiring surgery that are missed (false negatives), and 
the proportion of false positives or inconclusive/indeterminate results that if too high will result 
in patients having unnecessary surgery and associated morbidity, added to the burden of 
healthcare and block resources needed for patients that actually require surgical intervention. 
Future studies should be designed as end to end studies i.e. studies that examine the impact 
of accuracy on patient outcomes and include an economic evaluation. A study with this 
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design is more likely to identify the biopsy technique that maximises the use of these 
interventions and leads to better patient outcomes.  
The review process was limited by our inability to translate articles in languages other than 
English due to limited time and resources. In addition to the aforementioned weaknesses, 
there were limitations related to the available evidence. 
4.2.1 Paucity of evidence 
The majority of the included studies used retrospective data collection from registries or 
hospital records which may not contain the necessary information, like patients presenting 
with procedure complications to other hospitals or primary care providers. Overall there were 
not enough good quality primary studies that compared ultrasound guided FNA and CNB for 
the proposed head and neck subsites precluding pooling of results or investigation of 
heterogeneity for two subsites (salivary gland and cervical nodes). Thyroid malignancy was 
evaluated in six studies in similar settings. Salivary gland masses were evaluated in only one 
study. None of the included studies evaluated cervical lymph nodes. Complications were 
generally poorly recorded and consequently difficult to pool and analyse.  
Studies published as conference abstracts were excluded from this review as it was not 
possible to ascertain the eligibility and methodological quality of these studies, the authors 
were not contacted for further details due to limitations of time and resources. Of the studies 
presented as summaries or abstracts at meetings, only half of all studies and a third of 
randomised trials fail to be published in full.148 Studies with positive findings, studies from 
native English-speaking countries, with larger sample sizes are more likely to be published in 
literature introducing a publication bias.148 As this review relies on published literature, it is 
likely affected by publication bias.   
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4.2.2 Methodological quality of studies 
Most of the studies had unclear or moderate methodological concerns indicating high risk of 
bias.Given this high risk of bias the reported accuracy estimates may not accurately reflect 
the actual performance of the tests. Patient selection and patient flow posed the most 
significant concerns.  
Two prospective studies were at a high risk of selection bias because they failed to randomise 
CNB and FNA and did not clearly describe the selection process. Generally, sensitivity and 
specificity is not affected by prevalence if the spectrum of diseased and non-diseased 
remains constant. Large variations in populations and patient selection can present as large 
variation in prevalence and this likely affects accuracy.149 In this systematic review study 
samples varied considerably in terms of prevalence suggesting differences in the spectrum of 
included participants. 
With respect to patient flow through the studies and the timing of the index test and reference 
standard, half the studies were at high risk of bias (4/8).124, 140, 143, 144 This was largely 
because of an unexplained difference in the number of patients recruited and the number of 
patients finally analysed in the two x two tables, introducing a partial verification bias.  
Risk of bias regarding conduct of index tests and reference tests and the interpretation of the 
results could not be assessed due to failure of primary studies to provide sufficient 
information. The reference standard (surgical histopathology after excision vs clinical follow 
up) for diagnosis was poorly defined or only applied to an unspecified subset of cases in two 
studies.124, 140 
The same reference standard was not applied to all patients. Varying proportion of patients 
with benign pathology were followed up sonographically and clinically. Differential verification 
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of FNA and CNB poses a problem as reference standards differ in accuracy (histopathology 
of a nodule vs follow-up for detection of malignancy) and this affects the diagnostic test 
accuracy in turn introducing a risk of bias.  
Overall the studies were assessed to be at serious risk of bias and as such the summary 
accuracy data needs to be interpreted with awareness of these limitations. 
4.2.3 Sources of heterogeneity 
Heterogeneity secondary to variation in operators performing the test and their experience, 
the variety of needle sizes used for both techniques, the number of needle passes, the 
reference standards used were contributing variables identified in this study. These factors 
affect the sensitivity and post-procedure complication rates as well as non-diagnostic rates. It 
is therefore important to interpret the results of this review in the context of heterogeneity of 
data.  
Subgroup analysis of the different anatomical sites as planned was not possible due to 
inadequate number of published studies meeting our inclusion criteria. Post-hoc the following 
additional possible subgroup analyses were identified: 
• operator characteristics  
• nodule characteristics (solid vs cystic; macrocalcification vs no macrocalcifications) 
• Diagnostic accuracy for first line aspiration and core needle biopsy  
• Diagnostic accuracy of repeated fine needle aspiration and core needle biopsy in 
patients with prior nondiagnostic/indeterminate FNA results 
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4.3 Previously published meta-analyses compared to this review 
The results of this meta-analysis are consistent with the results from previous meta-analyses 
presented in Table 23. Only one meta-analysis systematically compared accuracy of FNA and 
CNB;98 however, this review was limited to thyroid nodules, made indirect comparisons 
between FNA and CNB and included studies that had patients <18 and non-ultrasound 
guided FNA. All the studies had similar methodological issues associated with diagnostic 
accuracy reviews, poor reporting, unclear patient flow and timing of index and reference tests, 
between study variation and heterogeneity and biased patient selection.  
The results of this meta-analysis are comparable with the results of other studies investigating 
the diagnostic accuracy of FNA and CNB in salivary gland masses, axillary lymph node 
metastases, and primary breast tumours.96, 116, 117 A meta-analysis that compared FNA and 
CNB for diagnosis of axillary lymph node metastases included 1353 patients from six studies. 
The findings suggested that CNB was a superior diagnostic technique with sensitivity of CNB 
(88%) being higher than sensitivity of FNA (75%) with a high specificity of 100%. The repeat 











Focus of review Summary 
sensitivity (95% CI) 
Summary 
specificity (95% CI) 
Summary adequacy 
(95% CI) 
Cao (2016)98 2942 (12) (1) compare the 
accuracy of C.N.B. 
and F.N.A. in the 
detection of thyroid 
malignancy; (2) 
evaluate the 
accuracy of C.N.B. 




FNA – 0.747 
(0.655, 0.822) 
FNA – 0.956 
(0.855, 0.988) 
OR 4.983 (Range 2.17 – 
11.19) favoring CNB 
CNB – 0.808 
(0.747, 0.857) 
CNB – 0.955 
(0.880, 0.984) 
Suh (2017)150 2240 (9) to evaluate the 
efficacy and safety 
of core needle 









CNB – range 
(0.447 – 0.85) 
Not pooled 
CNB – 1.00 
















FNA - 0.995 
(0.960–0.999) 
 










Focus of review Summary 
sensitivity (95% CI) 
Summary 

















Schmidt (2011)66 6169 (64) to summarize the 
evidence on the 
diagnostic accuracy 
of FNAC for parotid 
gland tumors 
 
FNA - 0.80 (0.76-
0.83) 
  
FNA - 0.97 (95% 
CI, 0.96-0.98) 
 
Not pooled – 8.6% 
inadequate/indeterminate 
Schmidt (2011) 152 403 (5) to obtain improved 




CNB - 0.92 (0.77-
0.98) 
 
CNB – 1.00 (0.99 – 
1.00) 
 
Not pooled – 1.2% 
 
Difference in adequacy 
rate calculated between 





Witt (2014)96 512 (5) To obtain summary 
estimates of the 
sensitivity and 
specificity of core 
needle biopsy for 
assessment of 
CNB – 0.96 (0.87–
0.99) 
 
CNB – 1.00 (0.84–
1.00) 
 








Focus of review Summary 
sensitivity (95% CI) 
Summary 










of core needle 
biopsy in the 
salivary glands. 
 
CNB - 0.94 (0.92-
0.96) 
 
CNB - 0.98 (0.97-
0.99) 
 
Not pooled - 3.26%  
Tandon (2008) 67 3459 (30) to assess the 
effectiveness of 
FNAC in the 
diagnosis of 
masses presenting 
in the head and 
neck by way of a 
systematic review 
of the literature and 
subsequent meta-
analysis of the raw 
data extracted from 
studies that fulfilled 
the inclusion 
criteria of the 
review 
 
FNA – 89.6 (CI not 
reported) 
FNA – 96.5 (CI not 
reported 
Not reported 
Novoa (2012) 20 1291 (16) to determine the 
role of CNB in the 
assessment of 
head and neck 
lesions 
 
CNB – 93% (CI not 
reported) 
CNB 99% (CI not 
reported) 






5.1 Implications for practice 
Percutaneous biopsy techniques are critical for surgical management of head and neck 
masses and have become the standard of care in preoperative diagnosis of neoplasms and 
malignancy. A correct diagnosis allows for prompt treatment in turn avoiding progression of 
disease. Diagnostic delays can lead to poorer prognosis and outcomes in some patients due 
to progression of the disease to an advanced stage.18 Sensitivity is key for a diagnostic biopsy 
test in order to avoid incorrectly clearing a patient that has a malignancy (false negative). 
However, in addition to high sensitivity, an ideal test will ensure that no patients undergo the 
risk of morbidity associated with unecessary surgery. The prime metric for determining a 
‘superior’ biopsy technique in addition to high sensitivity and specificity in our opinion is the 
inadequacy rate.  
This review’s findings suggest that core needle biopsy has consistently lower non-diagnostic 
and inconclusive rate with comparable sensitivity and specificity and similar risk profile to FNA 
for thyroid nodules.  
This review suggests that due to its high sensitivity and specificity, and low inadequacy and 
inconclusive rate CNB is certainly an appropriate test to triage individuals that need to 
undergo more invasive surgical management for thyroid nodules. Considering this and the 
similar safety profile, cost permitting, CNB could replace FNA in the clinical pathway in 
diagnosis of thyroid nodules, if not all head and neck masses.  
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Overall, the number of included studies was small, and most studies were at high risk of bias 
and there were substantial differences in study characteristics and large between-study 
heterogeneity in the reported accuracy estimates. Consequently, these findings should be 
treated with caution. Better designed studies are required to verify our provisional 
hypotheses. 
5.2 Implications for research 
Good quality primary diagnostic accuracy studies that make direct comparisons between 
ultrasound guided FNA and CNB either in a paired or a randomised unpaired methodology 
and present standardised reporting of core accuracy data following the STARD (Standards for 
the Reporting of Diagnostic Accuracy)153 statement are required to further assess the 
adequacy, accuracy and complications associated with each procedure.   The accuracy of 
CNB should be compared with that of FNA to assess if CNB should replace FNA as a 
diagnostic test, or alternatively be used only in patients with non-diagnostic/inconclusive 
results.  
There are limited or no studies diagnostic accuracy studies addressing salivary gland masses 
and cervical lymphadenopathy resulting in an inability to analyse and compare ultrasound 
guided FNA and CNB for these subsites. This needs to be addressed by further studies that 
assess and compare the safety and efficacy of the use of FNA and CNB for these sub sites to 
guide further management. 
The majority of the primary studies were of unclear or moderate risk of bias due incomplete 
reporting. Future studies need to address this by being transparent in their methodology and 
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ensuring that guidelines such as STARD are adhered to, and complete reporting of patients 
enrolled, patients lost to follow up, and patients undergoing the intervention arerecorded 
There is a paucity of cost-effectiveness data comparing ultrasound guided FNA and CNB for 
head and neck masses. The utility of CNB as a primary diagnostic test versus an ad hoc add 
on test with FNA will be affected by the cost factor. Primary studies of cost-effectiveness for 
each technique are critical for policy makers and clinicians to help make informed, cost-
effective decisions.   
An ideal cytological/histological test for identification of neoplasms and malignancy will have 
binary results neoplastic/non-neoplastic or malignant or non-malignant. However, inadequate 
samples or indeterminate results are a common finding that add variability to the results of 
diagnostic test accuracy studies. The Bethesda system for reporting thyroid cytology was 
established in 2009 to define intermediate cytology findings and to report risk of malignancy 
associated with each category. In our study, prior to the introduction of the Bethesda, some 
studies classified indetermediate results as benign increasing the false negative rate while 
other studies classified them as malignant increasing the false positive rate.123, 124 This 
inconsistency creates confusion in interpretation of data.66 Haematological malignancies have 
the French-American-British and World Health Organisation classification systems that assist 
in interpretation of bone marrow aspirates, similarly breast FNA has diagnostic categories.117, 
152 The standardisation of classification has helped researchers and clinicians in analysing, 
reporting and interpreting fine needle aspirates of thyroid nodules, breast nodules and bone 
marrow aspirates respectively. There is a need for standardisation of cytopathology reporting 
for salivary gland lesions and lymph node masses. Core needle biopsy also needs 
classification systems for histopathological analysis of head and neck lesions.  
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The diagnostic yield of addition of CNB as a diagnostic test for all patients undergoing FNA 
for investigation of head and neck masses was not investigated in this study and should be 
considered in future studies. Additionaly, the role of CNB in the diagnostic ladder as a test 
that is used as a triaging tool versus an add on test or whether it can replace FNA was not 


















Search strategy for PubMed 
(((((head[tiab] OR neck*[tiab] OR parathyroid[tiab] OR thyroid[tiab] OR cervical [tiab] OR 
salivary[tiab] OR parotid[tiab] OR sublingual[tiab] OR submandibular[tiab] OR 
lymphadenopath*[tiab] OR Lymph Node*[tiab] OR occipital[tiab] OR mastoid[tiab] OR 
maxillary[tiab] OR parotid[tiab] OR supramandibular[tiab] OR submandibular[tiab] OR 
submental[tiab] OR pre-auricular[tiab] OR preauricular[tiab] OR parathyroid[tiab] OR 
thyroid[tiab])))) OR (("head and neck neoplasms"[mh] OR Salivary Glands[mh] OR 
parathyroid glands[mh] OR thyroid gland[mh] OR thyroid nodule[mh] OR 
lymphadenopathy[mh] OR immunoblastic lymphadenopathy[mh] OR Lymph Nodes[mh])))) 
AND (((biopsy, fine-needle[mh] OR FNA[tiab] OR FNAB[tiab] OR FNAC OR fine 
needle*[tiab] OR fine-needle*[tiab] OR needle aspiration[tiab] OR UGFNAB[tiab] OR 
F.N.A[tiab] OR F.N.A.C[tiab])) AND (biopsy, large-core needle[mh] OR core needle*[tiab] 
OR CNB[tiab] OR NCB[tiab] OR cutting needle*[tiab] OR core biops*[tiab] OR core-
needle*[tiab] OR needle core[tiab])) 
PubMed (Medline) Search conducted on 2 March 2019 – 595 article hits 
 
Appendix II Search strategy 
 
 










Appendix IIV JBI Data extraction tool 
Author/Date   




Sample size   
Participant demographics (i.e. age, sex, spectrum of presenting 
symptoms, comorbidity, current treatments, recruitment centers) 
  
Study methodology (consecutive or random; retrospective or 
prospective) 
  
Period that study was carried out (beginning and end date)   
Index test description (including criteria for positive test)   
Reference test description (including criteria for positive test)   
Geographical location of data collection   
Setting of data collection   
Persons executing and interpreting index tests 
(numbers, training, and expertise) 
  
Persons executing and interpreting reference test   
Index/reference time interval (and treatments carried out in between)   
Distribution of severity of disease in those with target condition   
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Other diagnoses in those without target condition   
Adverse events from index test   
Adverse events from reference test   
 
Index test results 
Threshold= 
Condition positive Condition 
negative 
Total 
Index test positive 
(T+) 
      
Index test 
negative (T-) 
      











Appendix V Excluded studies and reason for exclusion 
Another language  
Zhang S, Niu L. [Evaluation of the efficacy and the limitation of ultrasound-guided core-needle 
biopsy, core-needle aspiration and fine-needle aspiration in micro-nodules of thyroid]. 
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;49 (11):893-6. 
Zhang W. Z, Yang G. Y, Xu J. P, Zhang L, Li J, Zhao D. [Comparative study of core needle 
biopsy and fine needle aspiration cytology in the diagnosis of neck lymph node diseases with 
contrast-enhanced ultrasound]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;51 
(8):615-7. 
Lemos JuÌ•nior Celso Augusto, Santos Ana Paula Candido dos AnaÌ•lise comparativa da 
puncÌ§aÌƒo aspirativa por agulha fina (PAAF) em relacÌ§aÌƒo a bioÌ•psia em cavidade oral e 
regiaÌƒo de cabecÌ§a e pescocÌ§o. 2010. 
Thierauf J, Hoffmann T. K, Bommer M, Veit J. A, Lindemann J. Value of Fine Needle 
Aspiration Cytology and Core Needle Biopsy in the Head and Neck Region. Laryngo-Rhino-
Otologie. 2015;94 (5):311-316. 
Conference abstract  
Ji J, Kim Y. K, Choi S. I, Kim J. H, Song Y, Kim J, Seo E. H, Min G. H. Thyroid core needle 
biopsy: Patients' pain and satisfaction compared to fine needle aspiration. European Thyroid 
Journal. 2016;5 (Supplement 1):111. 
Kim Y. K, Kim J. H, Sun Ji J. Malignant thyroid nodule in chronic lymphocytic thyroiditis: The 
value of core-needle biopsy. European Thyroid Journal. 2016;5 (Supplement 1):166. 
Waisman J, Hernandez O, Ljung B. M. Comparison of thyroid fine-needle aspiration and core 
needle biopsy. American Journal of Clinical Pathology. 2008;129 (5):824-824. 
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